UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K
 
(Mark One)
 
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended November 30, 2010
or
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the transition period from ________ to ________
 
Commission File No. 001-31643

CCA INDUSTRIES, INC.
(Exact Name of Registrant as specified in Charter)

DELAWARE
04-2795439
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)

200 Murray Hill Parkway, East Rutherford, New Jersey 07073
(Address of principal executive offices, including zip code)

(201) 330-1400
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of class
 
Name of each exchange on which registered
Common Stock, par value $0.01 per share
 
New York Stock Exchange: AMEX
Class A Common Stock, par value $0.01 per share
 
New York Stock Exchange: AMEX
Preferred Stock Purchase Rights
 
New York Stock Exchange: AMEX

Securities registered pursuant to Section 12(g) of the Act: NONE

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of The Securities Act.  Yes o  No x

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes o  No x
 


 
 

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days.  Yes x  No o
 
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding twelve months (or for such shorter period that the Registrant was required to submit and post such files).  Yes x   No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x.
 
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o
Accelerated filer o
Non-accelerated filer o
Smaller reporting company x
 
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes o   No x.
 
The aggregate market value of the voting stock held by non-affiliates of the Registrant (i.e., by persons other than officers and directors of the Registrant), at the closing sales price $5.51 on May 28, 2010, was as follows:

Class of Voting Stock
Market Value
   
5,514,866 shares; Common Stock, $.01 par value
$30,386,912

On February 25, 2011 there was 6,086,740 shares of Common Stock and 967,702 shares of Class A Common Stock of the Registrant outstanding.

 
 

 

CROSS REFERENCE SHEET

   
Headings in this Form
Form 10-K
 
10-K for Year Ended
Item No.
 
November 30, 2010
       
1.
Business
 
Business
       
1A.
Risk Factors
 
Risk Factors
       
1B.
Unresolved Staff Comments
 
Unresolved Staff Comments
       
2.
Properties
 
Property
       
3.
Legal Proceedings
 
Legal Proceedings
       
5.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
 
Market for the Company's Common Stock and Related Shareholder Matters
       
6.
Selected Financial Data
 
Selected Financial Data
       
7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
 
Management's Discussion and Analysis of Financial Condition and Results of Operations
       
7A.
Quantitative and Qualitative Disclosures about Market Risk
 
Quantitative and Qualitative Disclosures about Market Risk
       
8.
Financial Statements and Supplementary Data
 
Financial Statements and Supplementary Data
       
9.
Changes In and Dis- agreements With Accountants On Accounting and Financial Disclosure
 
Changes In and Dis- agreements With Accountants On Accounting and Financial Disclosure
       
9A.
Controls and Procedures
 
Controls and Procedures
       
9B.
Other Information
 
Other Information

 
- i -

 
 
     
Headings in this Form
 
Form 10-K
 
10-K for Year Ended
 
Item No.
 
November 30, 2010
       
10.
Directors, Executive Officers and Corporate Governance
 
Directors and Executive Officers of the Registrant
       
11.
Executive Compensation
 
Executive Compensation
       
12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder  Matters
 
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
       
13.
Certain Relationships and Related Transactions, and Director Independence
 
Certain Relationships and Related Transactions
       
14.
Principal Accounting Fees and Services
 
Principal Accountant Fees and Services
       
15.
Exhibits, Financial Statements Schedules
 
Exhibits, Financial Statements, Schedules, and Reports on Form8-K
 
 
- ii -

 
 
TABLE OF CONTENTS

Item
   
Page
       
PART I
     
       
 
1
1
 
1A.
6
 
1B.
10
 
2.
10
  3.
11
       
PART II
     
       
 
5.
12
 
6.
14
 
7.
15
 
7A.
30
 
8.
31
 
9.
32
 
9A.
32
 
9B.
34
       
PART III
     
       
 
10.
35
 
11.
38
 
12.
45
 
13.
47
 
14.
47
       
PART IV
     
       
 
15.
49
       
   
51
 
 
- iii -


PART I

Item 1. BUSINESS

Cautionary Statements Regarding Forward-Looking Statements

This annual report contains forward-looking statements based upon current expectations of management that involve risks and uncertainty.  Actual risks could differ materially from those anticipated.  Additional risks and uncertainties not presently known may possibly impair business operations.  If any of these risks actually occur, the business, financial conditions and operating results could be materially adversely affected.  The cautionary statements made in this Annual Report on Form 10K should be read as being applicable to all forward-looking statements whenever they appear in this Annual Report.

(a) General

CCA INDUSTRIES, INC. (hereinafter, “CCA” or the “Company”) was incorporated in Delaware in 1983.

The Company operates in one industry segment, in what may be generally described as the health-and-beauty aids business, selling numerous products in several health-and-beauty aids and cosmeceutical categories. All of the Company’s products are manufactured by contract manufacturers, pursuant to the Company's specifications and formulations.

The Company owns registered trademarks, or exclusive licenses to use registered trademarks, that identify its products by brand-name.  Under most of the brand names, the Company markets several different but categorically-related products.  The principal brand and trademark names include “Plus+White” (oral health-care products), “Sudden Change” (skin-care products), “Nutra Nail” and “Power Gel” (nail treatments), “Bikini Zone” (pre and after-shave products), “Mega - T” Green Tea (dietary products), “Mega – T” chewing gum (anti-oxidant dietary product), “Hair Off” (depilatories), “IPR” (foot-care products), “Solar Sense” (sun-care products), “Wash 'N Curl” (shampoos), “Cherry Vanilla” and other Vanilla fragrances (perfumes),  “Lobe Wonder” (ear-care product), Pain Bust*R II (topical analgesic) and “Scar Zone” (scar diminishing cream).

All Company products are marketed and sold to major drug, food chains, mass merchandisers and wholesale beauty aids distributors throughout the United States.  In addition, certain of the Company’s products are sold internationally, through distributors or directly.

The Company recognizes sales at the time its products are shipped to customers.  However, while sales are not formally subject to any contract contingency, returns are accepted if it is in the best interests of the Company’s relationship with the customer.  The Company thus estimates ‘unit returns’ based upon a review of the market’s recent-historical acceptance of subject products as well as current market-expectations, and equates its reserves for estimated returns based on the historical returns as a percentage of sales in the five preceding months, adjusting for returns that can be put back into inventory, and a specific reserve based on customer circumstances, (See Revenue Recognition in Note 2 of the Financial Statements).  Of course, there can be no precise going-forward assurance in respect to return rates and gross margins, and in the event of a significant increase in the rate of returns, the circumstance could have a materially adverse affect upon the Company’s operations.

 
- 1-


The Company's net sales in fiscal 2010 were $ 50,345,213. Gross profits were $28,537,204.  International sales accounted for approximately 4.4% of net sales.  The Company had a net loss of ($1,664,760) for fiscal 2010.   Net worth at November 30, 2010 was $26,818,351.

Including the principal members of management (see Directors and Executive Officers), the Company, at November 30, 2010, had 135 sales, administrative, creative, accounting, receiving, and warehouse personnel in its employ.

(b) Manufacturing and Shipping

The Company creates and/or oversees formulations, chooses colors and mixtures, and arranges with independent contractors for the manufacture of its products pursuant to Company specifications.  Manufacturing and component-supply arrangements are maintained with various manufacturers and suppliers.  All orders and other product shipments are delivered from the Company's own warehouse facilities, which results in more effective inventory control, more efficient shipping procedures, and the realization of related economies.

(c) Marketing

The Company markets its products to major drug, food and mass-merchandise retail chains, warehouse clubs and leading wholesalers, through an in-house sales force of employees and independent sales representatives throughout the United States, and through distributors internationally.

The Company sells its products to approximately 425 accounts, most of which have numerous outlets. Approximately 40,000 stores carry at least one Company product (SKU).

During the fiscal year ended November 30, 2010, the Company's largest customers were Wal-Mart (approximately 41% of net sales), Walgreens (approximately 13%), CVS (approximately 5%), Target (approximately 4%), Sam’s Club (approximately 4%), Dollar General (approximately 3%) and Rite Aid (approximately 3%).  The loss of any of these principal customers, or substantial reduction of sales revenues realized from their business, could materially and negatively affect the Company's earnings.

Most of the Company's products are not particularly susceptible to seasonal-sales fluctuation. However, retail sales of depilatory, sun-care and diet-aids products customarily peak in the Spring and Summer months, while fragrance-product sales customarily peak in the Fall and Winter months.

 
- 2-


The Company employs brand managers who are responsible for the marketing of CCA’s brands.  These managers work with the Company’s in-house advertising and art departments to create media advertising, packaging and point - of - purchase displays.

The Company primarily utilizes local and national television advertisements to promote its leading brands.  On occasion, print and radio advertisements are engaged.  In addition, and more-or-less continuously, store-centered product promotions are co-operatively undertaken with customers.

Each of the Company's brand-name products is intended to attract a particular demographic segment of the consumer market, and advertising campaigns are directed to the respective market-segments.

The Company's in-house advertising department is responsible for the selection of its media advertising.  Placement is accomplished either directly or through media-service companies.

(d) "Wholly-Owned" Products

The majority of the Company's sales revenues are from sales of the Company's "wholly-owned" product lines (i.e., products sold under trademark names owned by the Company, and not subject to any other party’s interest or license), which include principally "Plus+White", "Sudden Change", “Wash ‘N Curl”,  "Bikini Zone", "Mega -T", "Cherry Vanilla", and "Scar Zone".

(e) All Products

The Company’s gross sales net of returns by category percentage were: Dietary Supplements 33%; Skin Care 30%; Oral Care 20%; Nail Care 10%; Fragrance 4%, Analgesic 2%; and Hair Care and Miscellaneous 1%.

(f) License-Agreements Products

i. Alleghany Pharmacal

In 1986, the Company entered into a license agreement with Alleghany Pharmacal Corporation (the "Alleghany Pharmacal License").  The Alleghany Pharmacal License agreement provides that if, and when, in the aggregate, $9,000,000 in royalties had been paid thereunder, the royalty-rate for those products 'charged' at 6% would be reduced to 1%.  The Company paid an aggregate of $9,000,000 in royalties to Allegheny as of April 2003.  Commencing May 1, 2003, the license royalty was reduced to 1%.  The Company incurred royalties totaling $96,484 to Alleghany Pharmacal for the fiscal year ended November 30, 2010.

 
- 3-


ii. Solar Sense, Inc.

CCA commenced the marketing of its sun-care products line following a May 1998 License Agreement with Solar Sense, Inc. (the “Solar Sense License”), pursuant to which it acquired the exclusive right to use the trademark names "Solar Sense" and "Kids Sense” and the exclusive right to market mark-associated products.  The Solar Sense License requires the Company to pay a royalty of 5% on net sales of said licensed products until $1 million total royalties are paid, at which time the royalty rate will be reduced to 1% for a period of twenty-five years.  The Company incurred royalties of $71,232 to Solar Sense, Inc. for the fiscal year ended November 30, 2010.

iii. The Nail Consultants Ltd.

In October of 1999, the Company entered into a License Agreement with The Nail Consultants, Ltd. for the use of an activator invented in connection with a method for applying a protective covering to fingernails.  The Company’s License Agreement with The Nail Consultants, Ltd. is for the use of the method and its composition in a product kit packaged and marketed by CCA under its own name, “Nutra Nail Power Gel”.  The Company is required to pay a royalty of 5% of net sales of all products sold under the license, by the Company.   The Company incurred royalties totaling $4,631 to The Nail Consultants, Ltd. for the fiscal year ended November 30, 2010.  Effective December 1, 2010, the Company and The Nail Consultants, Ltd. agreed to eliminate the royalty on net sales and to increase the price that the Company pays for purchases of the activator from The Nail Consultants, Ltd.  The royalties previously paid were reported as part of selling, general and administrative expenses on the financial statements.  The increased cost of the activator will be reflected on the financial statements as part of cost of sales.

iv. Dr. Stephen Hsu - Green Tea

Stephen Hsu, PhD., research faculty member of the Medical College of Georgia, entered into an agreement with the Company on February 26, 2004, to create green tea skin care products based on his years of research related to the various uses of green tea anti-oxidants for skin care problems.  Dr. Hsu is entitled to a commission of 3% on the net factory sales of all of the Company’s products using the green tea serum created exclusively for the Company.  The Company incurred commissions totaling $42,174 to Dr. Hsu for the fiscal year ended November 30, 2010.  The Company had previously stopped using Dr. Hsu’s formula in its products.  Dr. Hsu notified the Company in a letter dated December 3, 2010 that he was terminating the agreement with the Company.

v. Tea-Guard Inc.

On May 18, 2004, the Company entered into a license agreement with Tea-Guard, Inc. to manufacture and distribute Mega -T Green Tea chewing gum and Mega -T Green Tea mints.  The license agreement required the Company to pay a royalty of 6% of net sales for the products sold under the license agreement.  The license agreement was amended on March 31, 2009, granting the Company a non-exclusive license, with no minimum royalty required.  The royalty rate of 6% of net sales will remain unchanged during the term, including any renewal terms, of the amended license agreement.  The Company commenced sales of the Mega -T Green Tea Chewing Gum in July 2004.  The Company incurred royalties to Tea-Guard, Inc. totaling $15,117 for the fiscal year ended November 30, 2010.

 
- 4-


vi. Continental Quest Corp.

Effective November 3, 2008, the Company entered into an agreement with Continental Quest Corp., to purchase certain United States trademarks and inventory relating to the Pain Bust*R II business for $285,106 paid at closing.  In addition, the Company agreed to pay a royalty equal to 2% of net sales of all Pain Bust*R II products, which are topical analgesics, until an aggregate royalty of $1,250,000 is paid, at which time the royalty payments will cease.  The Company incurred royalties to Continental Quest Corp. totaling $21,315 for the fiscal year ended November 30, 2010.

vii. Joann Bradvica

On March 22, 2002, the Company entered into an agreement with Joann Bradvica, granting the Company an exclusive license to manufacture and sell an Earlobe Patch Support for Earrings.  The agreement provided for a royalty of 10% of net sales of the licensed product.  A new agreement was entered into and effective on June 8, 2009 at the same royalty rate, and provides for a minimum royalty of $40,000 for annual periods beginning July 1, 2009 in order to maintain the license.  The Company incurred royalties of $38,053 to Joann Bradvica for the fiscal year ended November 30, 2010 (please note that minimum royalty is based on different time period).

viii.  LaRosa Innovations, LLC

On March 14, 2009, the Company entered into an agreement with LaRosa Innovation, LLC, granting the Company an exclusive license to manufacture and sell Instant Arm Lifts and Instant Thigh Lifts.  The agreement provides for a royalty of 5% of net sales until the Licensor receives $5,000,000 in aggregate royalties, at which time the royalty rate shall be reduced to 1% of net sales.  The license agreement provides for a minimum royalty of $150,000 for the first eighteen month period of the agreement, and $150,000 per year thereafter in order to maintain the license.  The Company incurred royalties of ($8,860) to LaRosa Innovations, LLC for the fiscal year ended November 30, 2010.  The Company informed LaRosa Innovations, LLC in May, 2010 that it was not going to continue marketing the licensed products.

ix. Other Licenses

The Company is not party to any other license agreement that is currently material to its operations.

 
- 5-


(g) Trademarks

The Company's own trademarks and licensed-use trademarks serve to identify its products and proprietary interests.  The Company considers these marks to be valuable assets.  However, there can be no assurance, as a practical matter, that trademark registration results in marketplace advantages, or that the presumptive rights acquired by registration will necessarily and precisely protect the presumed exclusivity and asset value of the marks.

(h) Competition

The market for cosmetics and perfumes, and health-and-beauty aids products in general, including patent medicines, is characterized by vigorous competition among producers, many of whom have substantially greater financial, technological and marketing resources than the Company.  Major competitors such as Revlon, L'Oreal, Colgate, Coty, Unilever, and Procter & Gamble have Fortune 500 status, and the broadest-based public recognition of their products.  Moreover, a substantial number of other health-and-beauty aids manufacturers and distributors may also have greater resources than the Company.

(i) Government Regulation

All of the products that the Company markets are subject or potentially subject to particular regulation by government agencies, such as the U.S. Food and Drug Administration, the Federal Trade Commission, and various state and/or local regulatory bodies.  In the event that any future regulations were to require new approval for any in-the-market products, or should require approval for any planned product, the Company would attempt to obtain the necessary approval and/or license, assuming reasonable and sufficient market expectations for the subject product.  However, there can be no assurance, in the absence of particular circumstances that Company efforts in respect of any future regulatory requirements would result in approvals and issuance of licenses.  Moreover, if such license-requirement circumstances should arise, delays inherent in any application-and-approval process, as well as any refusal to approve, could have a material adverse affect upon existing operations (i.e. concerning in-the-market products) or planned operations.

Item 1A. RISK FACTORS

Cautionary Statements for Purposes of the “Safe Harbor” Provisions of the Private Securities Litigation Reform Act of 1995

Our disclosure and analysis in this report contains forward-looking information that involves risks and uncertainties.  Our forward-looking statements express our current expectations or forecasts of possible future results or events, including projections of future performance, statements of management’s plans and objectives, future contracts, and forecasts of trends and other matters.  Forward-looking statements speak only as of the date of this filing, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur.  You can identify these statements by the fact that they do not relate strictly to historic or current facts and often use words such as “anticipate”, “estimate”, “expect”, “believe”, “will likely result”, “outlook”, “project” and other words and expressions of similar meaning.  No assurance can be given that the results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially.  The cautionary statements made in this Annual Report on Form 10K should be read as being applicable to all forward-looking statements whenever they appear in this Annual Report.  For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.

 
- 6-


Risk Factors

Concentration of Risk.

The Company relies on mass merchandisers and major food and drug chains for the sales of its products.  The loss of any one of those accounts could have a substantive negative impact upon our financial operations. All of the Company’s products have independent competition and must be able to compete in order to maintain our position on the retail merchandisers’ shelves. {See Business - General, Item 1(c) i Marketing.}

We are Dependent on Independent Contract Manufacturers.

The Company does not manufacture any of its products.  All of the products are manufactured for the Company by independent contract manufacturers.  There can be no assurance that the failure of a supplier to deliver the products ordered by the Company, when requested, will not cause burdensome delays in the Company’s shipments to accounts.  The Company does constantly seek alternative suppliers should a major supplier fail to deliver as contracted.  A failure of the Company to ship as ordered by its accounts could cause penalties and/or cancellations of our customers’ orders.

There is No Assurance That The Business Will Continue to Operate Profitably.

In fiscal 2010, net sales were $50,345,213.  Net loss was ($1,664,760).  There is no assurance that all of the Company’s products will be successful.   During 2010 consumer confidence was at a record low which had a general impact on the industry and retail sales.  There was a nation-wide trend of lower sales for all diet products in food, drug and mass market retailers.

 
- 7-


Competition in the Cosmetic, Health and Beauty Aid Industry is Highly Competitive.

Reference is made to “Business ‘Sub-section’ of Competition” (Item 1 (h)).

CLASS A Shareholders Retain Control of Board of Directors.

See “Voting” in the Proxy Statement dated May 17, 2010.  Class A Shareholders, David Edell and Ira W. Berman, who are directors of the Company, have the right to elect four members to the Board of Directors.  The holders of Common Stock have the right to elect three members to the Board of Directors.

The Company’s stockholder protection rights agreement could deter acquisition proposals and make it difficult for a third party to acquire control of the Company, which could have a negative effect on the price of the Company’s Common Stock.

The Company has a stockholder protection rights agreement, which could discourage potential acquisition proposals and could delay or prevent a change in control of the Company.  This deterrent could adversely affect the price of the Company’s Common Stock and make it difficult to affect a change in the composition of the Board of Directors or a change in management of the Company.

Future Success Depends on Continued Success of the Company’s Current  Products and New Product Development.

The Company is not financially as strong as the major companies against whom it competes.  The ability to successfully introduce new niche products and increase the growth and profitability of its current and new niche brand products will affect the business and prospects of the future of the Company and it relies upon the creativity and marketing skills of management.

All of the Company’s product must be in compliance with all FDA and state regulations and all products which are being manufactured for the Company by outside suppliers must conform to the FDA’s Good Manufacturing Practices requirements.  It is the Company’s responsibility to ascertain that the suppliers do conform.

The Company Relies On A Few Large Customers For A Significant Portion Of Its Sales.

In fiscal 2010, Wal-Mart Stores Inc. represented approximately 41% of the Company’s total revenues.   The Company’s ten largest customers accounted for 76% of the Company’s total revenues.  The Company has no agreements with any of its customers to stock its products.  The Company’s business would suffer materially if it lost Wal-Mart Stores, Inc. as a customer.  The loss of any of the Company’s ten top customers could have an adverse effect on the Company’s financial results.

 
- 8-


The Company’s Dietary Supplement Business Could Be Adversely Affected By Unfavorable Scientific Studies Or Negative Press.

The Company’s dietary supplement, Mega -T (Green Tea), to some extent is dependent on consumers’ perceptions, and the benefit and integrity of the dietary supplement business.  Any safety alert on any dietary supplement for weight loss may negatively affect the consumers’ perceptions of the product category.  Please see the Litigation section for information regarding the class action suit Denise Wally v. CCA Industries, Inc.

The Price of the Company’s Stock May Be Volatile.

The Company’s stock could fluctuate substantially.  There is a limited float of shares tradable.  There are factors beyond the Company’s control, including but not limited to variations in the Company’s operating revenues and profits, the timing of advertising commitments, the volatility of small cap stock in general, general stock market conditions, and quarter to quarter variations.

Climate Change Effects.

The Company continues to monitor climate changes for any potential impact on its business.  At this time, the Company does not anticipate that any climate change regulations will have a material impact on its operations or business.

We Depend on Key Personnel.

Our employees are key to the growth and success of our business.  This depends, in large part, on our ability to attract, retain and motivate qualified personnel, including our executive officers and key management personnel.  If we are unable to attract and retain key personnel, our operating results could be adversely affected.  David Edell and Ira Berman, who were the two founding members of the Company, retired as of December 31, 2010, and became consultants to the Company for a period of five years beginning January 1, 2011.

The Future Growth of the Company Depends on an Effective Marketing Program.

An effective marketing program includes media advertising, co-operative advertising with our retail partners and product promotions that increase product awareness and help generate increased sales for our customers.  Our inability to develop an effective advertising campaign, marketing or promotional programs, that would succeed in a difficult economic environment and highly competitive marketplace, could have a material adverse effect on our business.

We Sell to International Accounts.

International sales account for 4.4% of our total net sales.  Our international sales expose the Company to additional risks of different political or regulatory conditions, and the dependence on other economics.  A terrorist attack or the threat of a terrorist attack could prevent us from shipping to our international accounts.  A loss of our international sales would have a material adverse effect on our business.

 
- 9-


We Purchase Some Raw Materials or Components from International Suppliers.

Some of the components used in our products are sourced from international suppliers.  This exposes the Company to an additional risk of increased costs if the foreign currency exchange rates change unfavorably.  A terrorist attack or the threat of a terrorist attack could prevent the international suppliers from delivering their goods to the Company.  The interruption of the supply could have a material adverse effect on our business.

Item 1B.  UNRESOLVED STAFF COMMENTS

None

Item 2. PROPERTY

The principal executive offices of the Company are located at 200 Murray Hill Parkway, East Rutherford, New Jersey.  Under a net lease, the Company occupies approximately 58,625 square feet of space.  Approximately 43,598 square feet in such premises is used for warehousing and 15,027 square feet for offices.  The annual rental is $327,684, with an annual CPI increase not cumulatively exceeding 15% in any consecutive five year period. The lease expires on May 31, 2012 and had a renewal option at fair market value for an additional five years. The lease requires the Company to pay for additional expenses, Common Area Maintenance (“CAM”), which includes real estate taxes, common area expense, utility expense, repair and maintenance expense and insurance expense.  For the year ended November 30, 2010, CAM was estimated at $150,000.  The Company signed a new lease for the premises beginning June 1, 2012 and expiring May 31, 2022, with a renewal option for an additional five years.  The new lease will increase the space that the Company will rent to a total of 81,000 square feet, and the annual rental for this space will be $486,012, with a CPI increase not to exceed 30% in any consecutive five year period.  CAM is estimated to be $207,250 per year for future years beginning June 1, 2012.

On September 26, 2007, the Company entered into an additional lease for warehouse space located at 99 Murray Hill Parkway, East Rutherford, New Jersey, with Ninth Avenue Equities Co., Inc. for four and a half years commencing November 1, 2007 and ending on May 31, 2012.  The premises comprise 16,438 square feet of space.  The Company is obligated to pay maintenance which includes but is not limited to real estate taxes and all other common area expenses.  The annual rental is $123,285.  For the year ended November 30, 2010, CAM was $30,699.  The Company does not intend on renewing the lease at expiration.

 
- 10-


Item 3. LEGAL PROCEEDINGS

A class action lawsuit, “Wally v. CCA”, alleging false and misleading advertisement of the Company’s dietary supplement, was commenced in the Superior Court of the State of California, County of Los Angeles, on September 29, 2009. The action was brought seeking monetary and equitable remedies.  The Company denied all of the allegations of wrongdoing and liability in regard to its advertising. Nevertheless, it concluded that in the light of the costs, delays and risks, as well as the disruption that would be caused by the litigation and the legal expense to defend the action, it was in the best interest of the Company to settle the litigation.  The performance of any act of the Settlement Agreement, or any other circumstance regarding the parties’ agreement to settle, is not to be considered an admission of liability, or as an admission of any allegations made in any claim or litigation.

The settlement, subject to the Court’s final approval, provided for the deposit of Two Million Five Hundred Thousand dollars ($2,500,000) into a common fund to be dispersed as per provisions approved by the Court in the final Order of Settlement. On June 16, 2010, the Company deposited $2,500,000 into an escrow account to be used for the common fund upon the Court’s final approval. On September 28, 2010, the Court entered a Final Order and Judgment reconfirming their preliminary orders and settlement agreement.

The Company also entered into a settlement with its insurance carrier in regard to liability insurance coverage for litigation and settlement costs. The settlement calls for the insurance carrier to pay fifty percent (50%) of any combination of defense fees and related costs incurred for any settlement of, or any judgment on the released claims, up to a total of Four Hundred Seventy-Five Thousand dollars ($475,000). The obligation for the insurance carrier to make payments will cease once it has paid $475,000 to or on behalf of the Company.

The Company recorded a charge of $2,500,000 as an advertising litigation expense during the second quarter of 2010, with the resultant liability recorded as an accrued liability. To date, the Company has incurred legal fees related to the litigation of approximately $310,784, of which $100,319 was taken as a charge against earnings in the fourth quarter of fiscal 2009, $61,636 was taken as a charge against earnings in the first quarter of fiscal 2010, $42,407 was charged against earnings for the second quarter of fiscal 2010, $65,254 was charged against earnings for the third quarter of fiscal 2010 and $41,168 was charged against earnings for the fourth quarter of fiscal 2010. The Company also recorded, as a result of the insurance settlement, an insurance claim receivable of $475,000, during the second quarter of 2010. The advertising litigation expense was reduced by the amount of the insurance claim receivable. As of November 30, 2010, the insurance carrier has made payments of $113,361 against the Company’s claim, leaving an insurance receivable balance of $361,639.

There is no other material pending legal proceedings outstanding against the Company.

 
- 11-


PART II

Item 5. MARKET FOR THE COMPANY'S COMMON STOCK AND RELATED SHAREHOLDER MATTERS

The Company's Common Stock is traded on the New York Stock Exchange Amex under the symbol “CAW”.

The Company’s Class A Common Stock is not traded on any public market.

The range of high and low sales prices of the Common Stock during each quarter of its 2010 and 2009 fiscal years were as follows:

Quarter Ended
 
2010
   
2009
 
February 28
  $ 6.20 - $ 4.16     $ 2.55 - $ 4.24  
May 31
  $ 6.39 - $ 4.77     $ 2.05 - $ 3.40  
August 31
  $ 5.99 - $ 5.00     $ 2.74 - $ 4.20  
November 30
  $ 5.68 - $ 4.35     $ 5.50 - $ 3.81  

The high and low prices for the Company’s Common Stock, on February 2, 2011 were $5.95 to $5.81 per share.

As of November 30, 2010, there were approximately 138 individual shareholders of record of the Company’s common stock.  There are a substantial number of shares held of record in various street and depository trust accounts, which represent approximately 1,000 additional shareholders.

As of November 30, 2010, there were two individual shareholders of record of the Company’s Class A common stock.

The dividend policy is at the discretion of the Board of Directors and will depend on numerous factors, including earnings, financial requirements and general business conditions.

On December 5, 2007, the Board of Directors declared a $0.10 per share dividend for the first quarter ending February 29, 2008.  The dividend was paid to all shareholders of record as of February 1, 2008, and was paid on March 1, 2008.  On February 25, 2008, the board of directors declared an $0.11 per share dividend for the second quarter ending May 31, 2008.  The dividend was paid to all shareholders of record as of May 1, 2008, and paid on June 1, 2008.  On July 7, 2008, the board of directors declared an $0.11 per share dividend for the third quarter ending August 31, 2008.  The dividend was paid to all shareholders of record as of August 1, 2008, and paid on September 1, 2008.  On October 13, 2008, the board of directors declared a $0.11 per share dividend for the fourth quarter ending November 30, 2008.  The dividend was paid to all shareholders of record as of November 1, 2008, and paid on December 1, 2008.

 
- 12-


On January 28, 2009, the Board of Directors declared a $0.11 per share dividend for the 1st quarter ending February 28, 2009.  The dividend was payable to all shareholders of record as of February 3, 2009 and was paid on March 3, 2009.  On April 8, 2009 the board of directors

declared a $0.07 per share dividend for the second quarter of 2009.  The dividend was payable to all shareholders of record as of May 1, 2009 and was paid on June 1, 2009.  On June 29, 2009, the board of directors declared a $0.07 dividend for the third quarter of 2009.  The dividend was payable to all shareholders of record as of August 3, 2009 and was paid on September 3, 2009.  On October 12, 2009, the board of directors declared a $0.07 dividend for the fourth quarter of 2009.  The dividend was payable to all shareholders of record as of November 2, 2009 and was paid on December 2, 2009.

On December 21, 2009, the board of directors declared a $0.07 per share dividend for the first quarter ended February 28, 2010.  The dividend was payable to all shareholders of record as of February 1, 2010 and was paid on March 1, 2010.  On February 23, 2010, the Board of Directors declared a $0.07 per share dividend for the second quarter ended May 31, 2010.  The dividend was payable to all shareholders of record on May 3, 2010 and was paid on June 3, 2010.  On May 28, 2010, the Board of Directors declared a $0.07 per share dividend for the third quarter ended August 31, 2010. The dividend was payable to all shareholders of record on August 2, 2010 and was paid on September 2, 2010.  On October 13, 2010, the Board of Directors declared a $0.07 dividend for the fourth quarter ending November 30, 2010. The dividend was payable to all shareholders of record as of the close of business on November 1, 2010, and was paid on December 1, 2010.

On January 28, 2011, the Board of Directors declared a $0.07 per share dividend for the first quarter of 2011 to all shareholders of record as of February 10, 2011 and payable on March 10, 2011.

 
- 13-


Item 6. SELECTED FINANCIAL DATA

x
   
Year Ended November 30,
 
   
2010
   
2009
   
2008
   
2007
   
2006
 
Statement of Income
                             
Sales, Net
  $ 50,345,213     $ 57,001,999     $ 56,741,133     $ 59,832,157     $ 63,302,220  
Net (Loss) Income
    (1,664,760 )   $ 3,431,644     $ 1,412,886     $ 5,537,795     $ 5,604,251  
                                         
(Loss) Earnings Per Share:
                                       
Basic
  $ (0.24 )   $ 0.49     $ 0.20     $ 0.79     $ 0.80  
Diluted
  $ (0.24 )   $ 0.49     $ 0.20     $ 0.78     $ 0.79  
Weighted Average Number of Shares Outstanding - Basic
    7,054,442       7,054,442       7,054,442       7,029,611       7,034,276  
Weighted Average Number of Shares Outstanding - Diluted
    7,054,442       7,054,442       7,061,646       7,058,889       7,133,332  

Balance Sheet Data:
 
As At November 30,
 
   
2010
   
2009
   
2008
   
2007
   
2006
 
                               
Working Capital
  $ 22,531,597     $ 25,973,568     $ 23,836,264     $ 24,922,016     $ 22,295,983  
Total Assets
    36,555,590       39,789,203       39,345,861       39,903,876       36,516,571  
                                         
Total Liabilities
    9,737,239       9,569,355       11,091,982       9,153,558       9,131,780  
Total Shareholders’ Equity
    26,818,351       30,219,848       28,253,879       30,750,318       27,284,791  
                                         
Cash Dividends Declared per Common Share
  $ 0.28     $ 0.32     $ 0.43     $ 0.30     $ 0.24  

 
- 14-


Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our financial statements and the notes to those statements and other financial information appearing elsewhere in this report.

Our disclosure and analysis in this report contains forward-looking information that involves risks and uncertainties.  Our forward-looking statements express our current expectations or forecasts of possible future results or events, including projections of future performance, statements of management’s plans and objectives, future contracts, and forecasts of trends and other matters.  Forward-looking statements speak only as of the date of this filing, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur.  You can identify these statements by the fact that they do not relate strictly to historic or current facts and often use words such as “anticipate”, “estimate”, “expect”, “believe”, “will likely result”, “outlook”, “project” and other words and expressions of similar meaning.  No assurance can be given that the results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially.  The cautionary statements made in this Annual Report on Form 10K should be read as being applicable to all forward-looking statements whenever they appear in this Annual Report.  For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.

Overview

Net Loss for the year ended November 30, 2010 was ($1,664,760) as compared to net income of $3,431,644 for the year ended November 30, 2009.  Earnings were materially impacted by two events in fiscal 2010, which were the settlement of litigation related to the Company’s advertising of its dietary supplement brand, and the voluntary recall of an oral care product.  Earnings were also impacted by a 22.6% reduction in gross sales of the Company’s diet products.  In addition, net sales were lower in fiscal 2010 as compared to fiscal 2009 due to lower gross sales and higher sales incentives given to the Company’s retail partners.  The loss per share, fully diluted was $(0.24) for the year ended November 30, 2010 as compared to earnings per share of $0.49 for the year ended November 30, 2009.  The Company had net cash used in operations of ($2,638,605) for the year ended November 30, 2010 as compared to net cash provided of $3,905,182 for the year ended November 30, 2009.  Comprehensive loss was ($1,426,253) for fiscal 2010 as compared to income of $4,223,391 for fiscal 2009.  The Company had current assets of $32,141,970 and current liabilities of $9,610,373 at November 30, 2010.  Retained earnings decreased to $24,454,779 at November 30, 2010 from $28,094,783 at November 30, 2009.  There was no change in the number of outstanding shares at November 30, 2010 as compared to November 30, 2009.

 
- 15-



Comparison of Operating Results for Fiscal Years 2010 and 2009

For the year ended November 30, 2010, the Company had revenues of $50,811,642 and a net loss of $(1,664,760) after a benefit for income taxes of $(693,085).  For the year ended November 30, 2009, the Company had revenues of $57,672,164, and net income of $3,431,644, after a provision of $2,178,480 for taxes.  Other income declined to $466,429 as of November 30, 2010 as compared to $670,165 as of November 30, 2009.  The decrease was primarily due to lower interest and dividend income, as well as lower realized gains on sales of investments.  The basic and fully diluted loss per share for fiscal 2010 was $(0.24) as compared to basic and fully diluted earnings of $0.49 for fiscal 2009.

The Company’s net sales decreased to $50,345,213 for the fiscal year ended November 30, 2010 from $57,001,999 for the fiscal year ended November 30, 2009.  Net sales were affected by the following factors:

 
·
Gross sales were impacted by sales of the Company’s diet products, which were 22.6% lower in fiscal 2010 as compared to fiscal 2009.  This is part of a nation-wide trend of lower sales for all brands of diet products.
 
·
Sales continued to trend down for skin care products, although sales for the Solar Sense brand increased by over 90%.
 
·
Sales of oral care products increased 13.8% during fiscal 2010 as compared to fiscal 2009.  This increase occurred despite the Company’s recall in April 2010 of three lots of its whitening gel due to the gel liquefying which caused the product to lose its efficacy.  The recall caused the Company to cancel over six-hundred eleven thousand dollars of orders on hand at the time.
 
·
Gross sales of Pain Bust*R II, an analgesic product which was acquired in November 2008, increased 41.8% due to increased retail distribution.

Sales returns and allowances decreased to 11.4% of gross sales for fiscal 2010 versus 11.6% in fiscal 2009.  The decrease was primarily due to lower usage of coupons during fiscal 2010.  Coupon expense, charged against sales allowances, was $904,610 in fiscal 2010 as compared to $1,346,737 in fiscal 2009.  The Company, on an ongoing basis, has returns of products that have been phased out and replaced by new items as part of its marketing plan.  Returns as a percentage of gross sales was almost unchanged in fiscal 2010 as compared to fiscal 2009, despite returns of Plus White increasing 2.6% of gross sales during fiscal 2010 as a result of the whitening gel recall.

In accordance with accounting principles generally accepted in the United States of America (“GAAP”), the Company reclassified certain advertising and promotional expenditures as a reduction of sales rather than report them as an expense, which has no affect on the net income.  This reclassification is the adoption by the Company of ASC Topic 605-10-S99, “Revenue Recognition” as more fully described in Note 2 (“Sales Incentives”), of the consolidated financial statements for fiscal 2010.  The reclassification reflects a reduction in sales for the fiscal years ended November 30, 2010 and 2009 by $6,507,212 and $4,889,941 respectively, an increase in the net sales reduction of $1,617,271.

 
- 16-


The Company’s net sales, by category for fiscal 2010 as compared to fiscal 2009 were:

   
Years Ended November 30,
 
                         
   
2010
   
2009
 
Category
 
Net Sales
         
Net Sales
       
Dietary Supplement
  $ 16,695,074       33.2 %   $ 24,243,598       42.5 %
Skin Care
    15,074,631       29.9 %     15,807,074       27.7 %
Oral Care
    10,047,391       20.0 %     8,859,354       15.6 %
Nail Care
    5,039,085       10.0 %     5,529,822       9.7 %
Fragrance
    2,031,549       4.0 %     1,938,084       3.4 %
Analgesic
    803,228       1.6 %     617,554       1.1 %
Hair Care
    51,354       0.1 %     6,513       0.0 %
Misc.
    602,901       1.2 %     ---       0.0 %
    $ 50,345,213       100.0 %   $ 57,001,999       100.0 %

Gross profit margins decreased to 56.7% in fiscal 2010 from 61.7% in fiscal 2009.  The decrease was due in part to an increase in the Company’s co-operative advertising to 10.1% of gross sales in fiscal 2010 as compared to 7.0% in fiscal 2009.  This portion of the Company’s co-operative advertising is classified as a sales incentive, which reduces net sales.  The recall of the Plus White whitening gel caused the Company to change to another manufacturer who had higher labor charges, which resulted in a significant increase in the cost of sales.  The Company also had to reserve $219,171 of whitening gel inventory as a result of the recall, which was charged to cost of sales.  In addition, due to lower sales of the Company’s diet products the purchase volume decreased.  This resulted in an increase to the diet products cost of goods as the Company received lower quantity discounts from its raw material suppliers.

Selling, general and administrative expenses for fiscal 2010 were $21,139,743 as compared to $20,037,352 for fiscal 2009, an increase of $1,102,391.  The increase was mainly due to higher personnel costs.  The Company increased sales, marketing and other personnel during fiscal 2010.  The Company has since reduced its work force in response to the decrease in sales.  Health insurance costs increased $182,206 or 19.8% during fiscal 2010.  This increase is part of the national trend of increasing health insurance premium costs.  The Company had $92,236 of additional expenses related to the recall of the Plus White whitening gel which were included in selling, general and administrative expenses for fiscal 2010.

Advertising, cooperative and promotions expenses for fiscal 2010 were $7,493,282 as compared to $9,667,446 for fiscal 2009.  The decreased expense of $2,174,164 was comprised in part of the following:

 
·
A lower expense of $656,683 in fiscal 2010 as compared to fiscal 2009 due to cooperative advertising that was classified as a reduction of sales, rather than an expense

 
- 17-


 
·
Lower media, trade advertising and related expenses of $936,417
 
·
Decreased print advertising expense of $199,776

The Company’s advertising expense changes from year to year based on the timing of the Company’s promotions.

The Company recorded an advertising litigation expense of $2,235,465 in fiscal 2010.  This consists of settlement costs of $2,500,000 and litigation related legal expenses of $210,465, less a recovery of $475,000 from the Company’s insurance carrier.  A class action lawsuit, “Wally v. CCA”, alleging false and misleading advertisement of the Company’s dietary supplement, was commenced in the Superior Court of the State of California, County of Los Angeles, on September 29, 2009. The action was brought seeking monetary and equitable remedies.  The Company denied all of the allegations of wrongdoing and liability in regard to its advertising. Nevertheless, it concluded that in the light of the costs, delays and risks, as well as the disruption that would be caused by the litigation and the legal expense to defend the action, it was in the best interest of the Company to settle the litigation.  The performance of any act of the Settlement Agreement, or any other circumstance regarding the parties’ agreement to settle, is not to be considered an admission of liability, or as an admission of any allegations made in any claim or litigation.  Please see Item 3 – Legal Proceedings for further information regarding the litigation.

The loss before benefit for income taxes was $(2,357,845) for the year ended November 30, 2010, as compared to income before provision for income taxes of $5,610,124 for the year ended November 30, 2009.

The effective tax rate for fiscal 2010 was a benefit of 29.4% of the loss before tax as compared to a provision of 38.8% of income before tax for fiscal 2009.  The fiscal 2010 effective tax rate was a benefit due to the loss that the Company sustained during the year.  The United States Internal Revenue Service completed in 2009 an examination of the Company’s U.S. tax return for fiscal 2006.  As a result of that examination, the Company received a refund of $94,195 in federal taxes for the 2006 fiscal year.  The audit adjustments resulted in refunds from amended state tax returns for 2006 of $28,145, and an additional $196,335 in refunds from federal and state amended returns for fiscal 2007.  The refunds resulted in decreasing the effective tax rate for fiscal 2009.  The Company had $547,566 of officer salaries during fiscal 2010 that were not deductible for tax purposes in calculating the income tax benefit.   The Company also lost the benefit of the domestic production activities federal tax credit as a result of the operating loss.  As of November 30, 2010, the Company has unrealized losses on its investments of $60,950, which, if realized, would have a tax benefit of $24,929.

Comprehensive income decreased to $(1,426,253) for the year ended November 30, 2010 from $4,223,391 for the year ended November 30, 2009.  This reflects the Company’s net loss of $(1,664,760) together with other comprehensive income, net of income tax benefits, of $238,507.  The tax expense of the unrealized gain is $(14,972) for the year ended November 30, 2010.  The other comprehensive income is as a result of the increase in the market value of the Company’s investments.  Further information regarding the Company’s investments can be found in Note 6 of the consolidated financial statements.

 
- 18-


Comparison of Operating Results for Fiscal Years 2009 and 2008

For the year ended November 30, 2009, the Company had revenues of $57,672,164, and net income of $3,431,644, after a provision of $2,178,480 for taxes. For the year ended November 30, 2008, the Company had revenues of $57,457,946, and net income of $1,412,886, after a provision of $1,053,513 for taxes. Other income declined $46,648, primarily due to lower interest rates, partially offset by higher dividend income and realized gains on the sales of investments. Fully diluted earnings per share for fiscal 2009 were $0.49 as compared to $0.20 for fiscal 2008.

The Company’s net sales increased to $57,001,999 for the fiscal year ended November 30, 2009 from $56,741,133 for the fiscal year ended November 30, 2008. Gross sales were higher primarily in the diet and fragrance categories, and lower primarily in the oral care category. Sales returns and allowances were 11.6% of gross sales for fiscal 2009 versus 11.4% in fiscal 2008. In 2008 the Company had $321,070 of returns, primarily in the first three quarters of fiscal 2008, due to the discontinuance of Pound-X, a dietary supplement launched in the fourth quarter of 2006. Sales returns and allowances were higher in 2009 in part due to the Company’s continued expanded use of coupons. The coupon expense, charged against sales allowances, increased to $1,346,737 in fiscal 2009 from $884,161 in fiscal 2008. The Company, on an ongoing basis, has returns of products that have been phased out and replaced by new items as part of its marketing plan. Gross profit margins increased slightly to 61.7% in fiscal 2009 from 61.6% in fiscal 2008. The Company continually works to control its manufacturing costs.

In accordance with Generally Accepted Accounting Principles (“GAAP”), the Company reclassified certain advertising and promotional expenditures as a reduction of sales rather than report them as an expense, which has no affect on the net income. This reclassification is the adoption by the Company of ASC Topic 605-10-S99, “Revenue Recognition” as more fully described in Note 2 (“Sales Incentives”), of the consolidated financial statements for fiscal 2010. The reclassification reflects a reduction in sales for the fiscal years ended November 30, 2009 and 2008 by $4,889,941 and $4,557,507 respectively, an increase in the net sales reduction of $332,434.

Income before taxes was $5,610,124 for fiscal 2009 as compared to $2,466,399 for fiscal 2008, an increase of $3,143,725.  The increase was due to a reduction of expenses in both media and selling, general and administrative costs. For fiscal 2009, advertising, cooperative and promotional expenses were $9,667,446 as compared to $10,466,740 for fiscal 2008, or an expense decrease of $799,294. Advertising expenses were 17.0% of net sales for fiscal 2009 versus 18.4% for fiscal 2008. Included in advertising expense is media advertising, which decreased to $6,641,461 in fiscal 2009 from $8,051,849 in fiscal 2008. The Company increased its cooperative advertising in fiscal 2009, however a large portion of the increase in expense was offset by a decrease in the use of advertising in newspaper inserts.

 
- 19-


Cost of goods remained stable despite increases in resin prices during fiscal 2009. Selling, general and administrative expenses decreased to $20,037,352 in fiscal 2009 from $22,122,849 in fiscal 2008. The decrease was primarily due to lower freight out costs as a result of the decrease in fuel costs and renegotiation of some carrier rates, decreased selling expenses, lower personnel costs and decreased donations of the Company’s inventory.

Shipping costs to the Company’s customers, reported as part of selling, general and administrative costs, decreased in fiscal 2009 by $556,051 from fiscal 2008. Shipping costs as a percentage of gross sales decreased to 4.0% in fiscal 2009 from 4.9% of gross sales in fiscal 2008. This was due to lower fuel costs during fiscal 2009, and a renegotiation of rates with some of the Company’s carriers. The Company also had a decrease in personnel costs and other costs because of management’s cost control initiatives. The Company significantly decreased its donations of inventory during fiscal 2009, resulting in an expense that was $392,805 lower then fiscal 2008. Donations of inventory can result in an increased tax benefit, the unused portion of which creates a deferred tax benefit that may be utilized in future periods.

The effective tax rate for fiscal 2009 was 38.8% of income before tax as compared to 42.7% for fiscal 2008. The United States Internal Revenue Service completed an examination of the Company’s U.S. tax return for fiscal 2006. As a result of that examination, the Company received a refund of $94,195 in federal taxes for the 2006 fiscal year. The audit adjustments resulted in refunds from amended state tax returns for 2006 of $28,145, and an additional $196,335 in refunds from federal and state amended returns for fiscal 2007. The refunds resulted in the decreased effective tax rate for fiscal 2009. The State of New Jersey, Department of The Treasury, Division of Taxation is currently examining state income and sales tax returns filed for the fiscal years 2004 — 2008. As of February 25, 2010, no adjustments have been proposed. No other state has notified the Company of its intent to conduct an examination of tax returns filed in their jurisdictions. The Company had $747,668 of officer salaries during fiscal 2009 that were not deductible for tax purposes in calculating the income tax provision. As of November 30, 2009, the Company has unrealized losses on its investments of $314,428, which would have a tax benefit of $125,457. This tax benefit has been reduced by a valuation allowance of $85,557. The valuation allowance is based on an estimate of the losses, which if realized, could not be utilized to offset any corresponding capital gains. The tax benefit of the unrealized losses, net of valuation allowances, is $39,900 as of November 30, 2009.

Comprehensive income increased to $4,223,391 for the year ended November 30, 2009 from $536,972 for the year ended November 30, 2008. This reflects the increase in the Company’s net income together with other comprehensive income, net of income tax benefits, of $791,747. The tax benefit of the unrealized losses, net of valuation allowances, is $39,900 as of November 30, 2009. The other comprehensive income is as a result of the increase in the market value of the Company’s investments. Further information regarding the Company’s investments can be found in Note 6 of the consolidated financial statements.

 
- 20-


Financial Position as of November 30, 2010

As of November 30, 2010, the Company had working capital of $22,531,597 as compared to $25,973,568 at November 30, 2009.  The ratio of total current assets to current liabilities is 3.3 to 1 as compared to a ratio of 3.7 to 1 for the prior year.  The Company’s cash position and short-term investments at November 30, 2010 were $12,738,103, versus $17,480,472 as at November 30, 2009.  Non-current or long term investments were $3,124,051 at November 30, 2010 versus $2,900,035 at November 30, 2009.  The Company paid cash dividends during fiscal 2010 in the amount of $1,975,244.  This amount includes the dividends declared at the end of fiscal 2009 but not paid until fiscal 2010 of $493,811 and $1,481,433 in dividends declared and paid for fiscal 2010.  As of November 30, 2010, there were dividends declared but not paid of $493,811.  The investment securities the Company purchased are all classified as “Available for Sale Securities”, and are reported at fair market value as of November 30, 2010, with the resultant unrealized gains or losses reported as a separate component of shareholders’ equity.  Due to the current securities market conditions, the Company cannot ascertain the risk of any future change in market value. Our investments are spread among many different obligors and municipalities to decrease the risk due to any specific concentrations.

Accounts receivable as of November 30, 2010 and 2009 were $5,990,010 and $7,613,273 respectively.  The gross accounts receivable was $793,778 lower as of November 30, 2010 versus November 30, 2009 due to lower sales volume.  Included in net accounts receivable are an allowance for doubtful accounts, a reserve for returns and allowances and a reduction based on an estimate of co-operative advertising that will be taken as credit against payments.  The allowance for doubtful accounts was $24,739 and $131,223 for November 30, 2010 and 2009, respectively. The allowance for doubtful accounts is a combination of specific and general reserve amounts relating to accounts receivable.  The general reserve is calculated based on historical percentages applied to aged accounts receivable and the specific reserve is established and revised based on individual customer circumstances.

The reserve for returns and allowances is based on the historical returns as a percentage of sales in the five preceding months, adjusting for returns that can be put back into inventory, and a specific reserve based on customer circumstances.  This allowance decreased to $2,555,099 as of November 30, 2010 from $2,660,469 as of November 30, 2009.  Of this amount, allowances and reserves in the amount of $1,316,589, which are anticipated to be deducted from future invoices, are included in accrued liabilities.  The decrease in the reserve for returns and allowances is due to the timing of the Company’s sales.  In addition, contained within the reserve as of November 30, 2009 was a provision of $293,845 for the Company’s Instant Lift product which was launched during fiscal 2009.  The product was returned to the Company during fiscal 2010, with the credit to the customer charged against the provision, eliminating the balance.

Gross receivables were further reduced by $1,778,547 as of November 30, 2010, which was reclassified from accrued liabilities, as an estimate of the co-operative advertising that will be taken as a credit against payments.  In addition, accrued liabilities include $1,610,236, which is an estimate of co-operative advertising expense relating to fiscal 2010 sales which are anticipated to be deducted from future invoices rather than current accounts receivable.

 
- 21-


Inventories were $9,077,234 and $8,327,277, as of November 30, 2010 and 2009, respectively.  The inventory, which was purchased in anticipation of forecasted sales, increased as a result of the slowdown in customer shipments that occurred during the fourth quarter of 2010.  The reserve for inventory obsolescence is based on a detailed analysis of inventory movement. The inventory obsolescence reserve was increased to $1,372,798 as of November 30, 2010 from $760,001 as of November 30, 2009.  Included in the reserve increase was $219,171 as a result of the voluntary recall of the Plus White whitening gel inventory.  This additional reserve reflects the cost of the recalled product that remained in inventory as of November 30, 2010.  Changes to the inventory obsolescence reserves are recorded as an increase or decrease to the cost of goods.

The Company recorded an insurance claim receivable in the amount of $475,000 during the second quarter of 2010 as a result of the advertising litigation (please see Item 3 – Legal proceeding for further information regarding the litigation).  The Company subsequently received payments from its insurance carrier of $113,361 during fiscal 2010, leaving an insurance claim receivable balance of $361,639.  The balance of the insurance claim receivable was paid during the first quarter of 2011.

Prepaid expenses and sundry receivables increased to $976,108 as of November 30, 2010 from $739,139 as of November 30, 2009.  The increase was mainly due to accounts payable invoices paid at the end of November 2010 that had due dates in the beginning of December 2010.

Prepaid and refundable income taxes increased to $999,702 as of November 30, 2010, from $89,535 as of November 30, 2009.  The increase was a result of estimated tax payments that were made during fiscal 2010 and tax overpayments from the Company’s 2009 income returns that were carried forward as estimated tax payments.  The Company will seek to have the payments refunded when it files its 2010 tax returns.

The amount of deferred income tax reflected as a current asset increased to $1,999,174 as of November 30, 2010 from $1,193,745 as of November 30, 2009.  Of the $805,429 increase, $560,257 was the recording of a deferred tax asset as a result of the net operating loss that occurred during fiscal 2010.  The balance of the increase of the deferred tax asset was as a result of increases in the Company’s reserves for bad debt and obsolete inventory during fiscal 2010, and an increase in charitable contributions that could not be deducted due to the Company’s operating loss and were carried forward.  The increase was partially offset by a reduction in the reserve for returns.  Also included is a deferred income tax asset of $24,929, as of November 30, 2010, as a result of the unrealized losses on the Company’s marketable securities, as compared to $125,457 as of November 30, 2009.  The Company had reported a valuation allowance of $85,557 as of November 30, 2009 against the deferred tax benefit resulting from the unrealized losses on investments.  There is no valuation allowance against the deferred tax benefit from unrealized losses at November 30, 2010, as the Company believes that if the unrealized losses were realized, the full amount of the deferred tax benefit would also be realized in the subsequent twelve months, based on capital gain earned over the prior three years and anticipated gains over the next year.

 
- 22-


The Company’s investment in property and equipment consisted mostly of computer hardware and software, racking for our warehouse facilities, leasehold improvements and furniture to accommodate our personnel in addition to tools and dies used in the manufacturing process.  The Company acquired $95,058 of additional property and equipment during fiscal 2010.

Current liabilities are $9,610,373 and $9,469,873, as of November 30, 2010 and 2009 respectively.  Current liabilities at November 30, 2010 consisted of accounts payable, accrued liabilities, short-term capital lease obligations and dividends payable.  As of November 30, 2010, there was $3,196,093 of open cooperative advertising commitments, of which $2,372,139 is from 2010, $457,685 is from 2009, $92,181 is from 2008, $258,528 is from 2007 and $15,559 is from 2006.  Of the total amount of $3,196,093, $1,778,547 is reflected as a reduction of gross accounts receivables, and $1,417,546 is recorded as an accrued expense.  Any changes to the amount of co-operative advertising reflected as an accrued expense are recorded as a debit or credit to the reserve for returns and allowances account.  Cooperative advertising is advertising that is run by the retailers in which the Company shares in part of the cost.  If it becomes apparent that this cooperative advertising was not utilized, the unclaimed cooperative advertising will be offset against the expense during the fiscal year in which it is determined that it did not run.  This procedure is consistent with the prior year’s methodology with regard to the accrual of unsupported cooperative advertising commitments.

The Company’s long term obligations are for a portion of its capitalized leases, which is for certain office and warehouse equipment and deferred tax liabilities.  The deferred tax liability increased to $118,717 as of November 30, 2010 as compared to $76,929 as of November 30, 2009.  The liability is due to the difference in depreciation between the Company’s books and income tax returns.

Stockholders’ equity decreased to $26,818,351 in fiscal 2010 from $30,219,848 in fiscal 2009.  The decrease was due to decreases in retained earnings as a result of operating losses and dividends issued, offset partially by lower unrealized losses on marketable securities.  Retained earnings decreased to $24,454,779 at November 30, 2010 from $28,094,783 at November 30, 2009.  The decrease was due to a net loss of $(1,664,760) during fiscal 2010 and dividends declared of $1,975,244. Unrealized losses on marketable securities were $(36,021) at November 30, 2010 as compared to unrealized losses of $(274,528) at November 30, 2009.  Unrealized gains or losses reflect the difference between the cost and market price of the Company’s marketable securities as of the date of the financial statements, net of any tax expense or benefit.  See Note 6 of the consolidated financial statements for further information regarding the Company’s marketable securities.  The Company did not purchase any treasury stock during fiscal 2010.  There were no common or preferred stock shares issued during fiscal 2010.

The Company had $(2,638,605) that was used in operating activities during fiscal 2010, as compared to $3,905,182 that was provided by operating activities in fiscal 2009.  The decrease in operating cash flow was mainly due to the decrease in net income, increases in deferred income taxes, inventory, insurance claim receivable and prepaid and refundable income taxes, and decreases in income taxes payable, partially offset by a decrease in accounts receivable and an increase in accounts payable and accrued liabilities.  The Company’s operating cash flow was materially impacted by the advertising litigation expense of $2,235,465 during fiscal 2010.  Net cash provided by investing activities was $4,886,178 during fiscal 2010, generated by the excess of the proceeds from the sale of some of the Company’s investments less securities purchased and the acquisition of equipment.  The Company’s cash balance increased by $219,886 during fiscal 2010, net of $1,975,244 in dividends paid to the shareholders.

 
- 23-


Liquidity and Capital Resources

Liquidity is defined as the ability to generate adequate amounts of cash to meet short-term and long-term business needs.  We assess our liquidity in terms of our total cash flow and the amounts of cash, short-term and long-term marketable securities on hand.  Significant factors that could affect our liquidity include the following:

 
·
Cash flow generated or used by operating activities;
 
·
Dividend payments;
 
·
Capital expenditures;
 
·
Acquisitions.

Our primary capital needs are seasonal working capital requirements and dividend payments.  In addition, funds are kept on hand for any potential acquisitions, which the Company continues to explore.  As of November 30, 2010, the Company had $4,673,848 of short-term marketable securities and $3,124,051 of non-current securities.  The Company’s cash and cash equivalents together with both short and long term marketable securities, net of current liabilities were $6,251,781 as of November 30, 2010.  The Company’s long term liabilities as of November 30, 2010, consist of deferred income tax liability of $118,717 and long-term capitalized lease obligations of $8,149.  The Company does not have any bank debt or a bank line of credit.  Due to the amount of cash and marketable securities on-hand, the Company does not believe that it needs the availability of a bank line of credit at this time.  The Company believes that it has sufficient capital resources to meet its working capital requirements for the fiscal 2011 year.

Critical Accounting Estimates

 Our consolidated financial statements include the use of estimates, which management believes are reasonable.  The process of preparing financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions regarding certain types of assets, liabilities, revenues, and expenses.  Such estimates primarily relate to unsettled transactions and events as of the date of the financial statements.  Accounting estimates and assumptions are those management considers to be most critical to the financial statements because they inherently involve significant judgment and uncertainties.  All of these estimates and assumptions reflect management’s best judgment about current economic and market conditions and their effects on the information available as of the date of the consolidated financial statements.  Accordingly, upon settlement, actual results may differ from estimated amounts.

 
- 24-


An accounting estimate is deemed to be critical if it is reasonably possible that it subsequent correction could have a material effect on future operating results or financial condition.  The following are estimates that management has deemed to be critical:

 
1.
Reserve for Returns - The allowances and reserves which are anticipated to be deducted from future invoices are included in accrued liabilities. The estimated reserve is based in part on historical returns as a percentage of gross sales.  The current estimated return rate is 8.4% of gross sales.  Management estimates that 37.6% of returns received are placed back into inventory, and the estimate for returns is adjusted to reflect the value of the returns placed into inventory.
 
2.
Allowance for Doubtful Accounts – The allowance for doubtful accounts is an estimate of the loss that could be incurred if our customers do make required payments.  Trade receivables are periodically evaluated by management for collectability based on past credit history with customers and their current financial condition.  Changes in the estimated collectability of trade receivables are recorded in the results of operations for the period in which the estimate is revised.  Estimates are made based on specific disputes and additional reserves for bad debt based on the accounts receivable aging ranging from 0.35% for invoices currently due to 2.0% for invoices more than ninety-one days overdue.  Trade receivables that are deemed uncollectible are offset against the allowance for uncollectible accounts.  The Company generally does not require collateral for trade receivables.
 
3.
Inventory Obsolescence Reserve – Management reviews the inventory records on a monthly basis.  Management deems to be obsolete finished good items that are no longer being sold, and have no possibility of sale within the ensuing twelve months.  Components and raw materials are deemed to be obsolete if management has no planned usage of those items within the ensuing twelve months.  In addition, management conducts periodic testing of inventory to make sure that the value reflects the lower of cost or market.  If the value is below market, a provision is made within the inventory obsolescence reserve.  This reserve is adjusted monthly, with changes recorded as part of cost of sales in the results of operations.

Inventory, Seasonality, Inflation and General Economic Factors

The Company attempts to keep its inventory for its product at levels that will enable shipment against orders within a three-week period.  However, certain components must be inventoried well in advance of actual orders because of time-to-acquire circumstances.   For the most part, purchases are based upon anticipated quarterly requirements, which are projected based upon sales indications received by the sales and marketing departments, and general business factors.  All of the Company's contract manufactured products and components are purchased from non-affiliated entities.  Warehousing is provided at Company facilities, and all products are shipped from the Company's warehouse facilities.

 
- 25-


The Company’s products are not particularly seasonal, but sales of its sun-care, depilatory and diet-aid products usually peak during the spring and summer seasons, and perfume sales usually peak in fall and winter.  The Company does not have a product that can be identified as a ‘Christmas item’.

The Company plans to continue to promote its sales through an advertising program consisting of a combination of media and co-op advertising. We continue to invest money into research and development to build our core products to become leaders in their respective categories. We are trying to decrease the amount of “on hand” inventory we stock; however to better service our customers we often find it difficult to reduce our “safety stock”. We continue to evaluate our sales staff and to try to attract aggressive salespeople to increase the distribution of our current product line. We are also continuing to look for additional businesses or product lines which we think will help the Company to grow and are also reviewing possible acquisitions or any other offers which we feel will enhance shareholders’ value.

Because our products are sold to retail stores (throughout the United States and, in small part, abroad), sales are particularly affected by general economic conditions.  Accordingly, any adverse change in the economic climate can have an adverse impact on the Company's sales and financial condition.  The Company does not believe that inflation or other general economic circumstances that would further negatively affect operations can be predicted at present, but if such circumstances should occur, they could have material and negative impact on the Company's net sales and revenues, unless the Company was able to pass along related cost increases to its customers.

Contractual Obligations

The following table sets forth the contractual obligations as of November 30, 2010.  Such obligations include the current lease for the Company’s premises, written employment contracts and License Agreements.
 
   
Less than
               
More than
 
   
1 Year
   
1-3 Years
   
3-5 Years
   
5 years
 
Leases on Premises (1)
  $ 694,120     $ 1,386,953     $ 1,386,524     $ 4,506,203  
Royalty Expense (2)
    40,000       80,000       80,000       40,000  
Employment Contracts (3)
    2,063,611       3,641,109       3,363,322       144,186  
Other Operating Leases
    128,634       110,877       12,824       ---  
Capital Lease Obligations
    15,196       8,154       ---       ---  
Open Purchase Orders
    3,689,180       ---       ---       ---  
Total Contractual Obligations
  $ 6,630,741     $ 5,227,093     $ 4,842,670     $ 4,690,389  

 
- 26-


(1)
The major lease is a net lease requiring a yearly rental of $390,835 plus Common Area Maintenance “CAM”.  See Section Part I, Item 2. The rental provided above is the base rental and estimated CAM.  CAM for future years is estimated at $150,000 up to the expiration of the lease. The lease has an annual CPI adjustment, not to cumulatively exceed 15% in any consecutive five year period.  The lease expires on May 31, 2012 and had a renewal option at fair market value for an additional five years. The Company signed a new lease for the premises beginning June 1, 2012 and expiring May 31, 2022, with a renewal option at fair market value for an additional five years.  The new lease will increase the space that the Company will rent to 81,000 square feet, and the annual rental for this space will be $486,012, with a CPI increase not to exceed 30% in any consecutive five year period.  CAM has been estimated at $207,250 per year for future years beginning June 1, 2012.  On September 26, 2007, the Company entered into a warehouse lease with Ninth Avenue Equities Co., Inc. to lease 16,438 square feet of space known as Unit B located at Murray Hill Industrial Center in East Rutherford, New Jersey for a four and a half year period.  The annual rental is $123,285 plus CPI adjustments, real estate taxes and common area maintenance expenses.  CAM is estimated at $30,000 per year for future years. The Company does not intend on renewing the lease upon the expiration at May 31, 2012.  The figures for both leases above do not include adjustments for future CPI.

(2)
See Section Part I, Item 1(f).  The Company is not required to pay any royalty in excess of realized sales if the Company chooses not to continue under the license.  The figures set forth above reflect estimates of the royalty expense anticipated minimum requirements to maintain the licenses under the various contracts for the licensed products based on fiscal 2010 sales. The more than 5 years column only reflects one year of minimum payments; the payments can continue in perpetuity in order to maintain the license.  Royalty expense noted is for Joann Bradvica.

(3)
The Company had executed Employment Contracts on December 1, 1993, with its former Chief Executive Officer, David Edell, and its former Corporate Secretary, Ira W. Berman. The contracts for both are exactly the same.  Employment under the contracts expired on December 31, 2010, and Edell/Berman became consultants for an ensuing five years in accordance with the provisions of the contract.  For the consulting services provided, Edell/Berman shall be paid consideration equal to 50% of their annual base salary plus bonus that they received in 2010. Under the provisions of the Employment Contracts, the consulting payments will increase six (6%) percent for each successive year of the consulting term.  Edell/Berman are also entitled to all benefits that they had previously received as employees for the duration of the consulting term.  The figures above include the consulting payments due under the contracts and the yearly six (6%) percent increase for the successive years of the consulting period.  Mr. Berman remains as Chairman of the Board, and both Mr. Edell and Mr. Berman remain as directors of the Company.  During the employment period, the contracts had provided for a base salary which commenced in 1994 in the amount of $300,000 (plus a bonus of 20% of the base salary), with a year-to-year CPI of 6% increase, plus 2.5% of the Company’s pre-tax income plus depreciation and amortization plus certain fringe benefits including the cost of certain life insurance, auto expenses,  and health insurance.  The 2.5% measure in the bonus provision of the Edell/Berman contracts was amended on November 3, 1998 so as to calculate it against earnings before income taxes, plus depreciation, amortization and expenditures for media and cooperative advertising in excess of $8,000,000.  On May 24, 2001, the contract was amended increasing the base salary then in effect by $100,000 per annum.  On June 1, 2001, the Company added a provision to the Contracts stating that in the event of death within the employment and consulting periods, the Company would be obligated for two successive years to pay the executive’s estate an amount equal to their total compensation at that time.

 
- 27-


David Edell’s sons, Dunnan Edell and Drew Edell have five-year employment contracts in the amounts of $270,000 and $200,000 respectively, which expired on November 30, 2007 (See Item 11, Summary Compensation Table).  In July 2003, Dunnan Edell’s salary was increased to $300,000 and in January 2004, Drew Edell’s salary was increased to $225,000.  In fiscal 2005, Drew Edell’s salary was increased to $250,000.  Dunnan Edell is a director and during fiscal 2003 was appointed President of the Company and Chief Operating Officer. Drew Edell is the Executive Vice President of Research, and Product Development.

On February 10, 2006, the Board of Directors extended the employment contracts for Dunnan Edell and Drew Edell to December 31, 2010.  On May 17, 2007, the employment contracts for Dunnan Edell and Drew Edell were amended by the Board of Directors, extending the contracts to November 30, 2012, and increasing Dunnan Edell’s base salary to $350,000 and Drew Edell’s base salary to $275,000.  Dunnan Edell became Chief Executive Officer of the Company, effective December 1, 2011.

Recent Accounting Pronouncements

In December 2007, the Financial Accounting Standards Board (“FASB”) amended certain provisions of Accounting Standard Codification (“ASC”) Topic 805, “Business Combinations”.  This amendment changes accounting for acquisitions that close beginning in 2009 in a number of areas including the treatment of contingent consideration, contingencies, acquisition costs, in-process research & development and restructuring costs.  More transactions and events will qualify as business combinations and will be accounted for at fair value under the new standard.  This amendment promotes greater use of fair values in financial reporting. In addition, under Topic 805, changes in deferred tax asset valuation allowances and acquired income tax uncertainties in a business combination after the measurement period will impact income tax expense. Some of the changes will introduce more volatility into earnings.  Topic 805 became effective for fiscal years beginning on or after December 15, 2008.  Topic 805 will have an impact on accounting for any business acquired after the effective date of this pronouncement.

In April 2008, the FASB amended certain provisions of ASC Topic 350, “Intangibles-Goodwill and Other”.  Topic 350 amends the factors that must be considered in developing renewal or extension assumptions used to determine the useful life over which to amortize the cost of a recognized intangible. It further requires an entity to consider its own assumptions about renewal or extension of the term of the arrangement, consistent with its expected use of the asset, and is an attempt to improve consistency between the useful life of a recognized intangible asset and the period of expected cash flows used to measure the fair value of the asset.  Topic 350 became effective for fiscal years beginning after December 15, 2008, and the guidance for determining the useful life of a recognized intangible asset must be applied prospectively to intangible assets acquired after the effective date. Topic 350 will not have a significant impact on the Company’s results of operations, financial condition or liquidity.

 
- 28-


In April 2009, the SEC issued Staff Accounting Bulletin No. 111 (“SAB No. 111”).  SAB No. 111 amends Topic 5.M. in regard to other than temporary impairment of certain investments in debt and equity securities.  SAB No. 111 confirms the establishment of the “other than temporary” category of investment impairment.  The adoption of SAB No. 111 became effective upon issuance and did not have any material impact on the Company’s financial position or results of operation.

In April 2009, the FASB issued an amendment to ASC Topic 825, “Financial Instruments”.  The amendment requires disclosure of the fair value of financial instruments for interim reporting periods of publicly traded companies as well as in annual financial statements.  The amendment to Topic 825 became effective for interim reporting periods ending after June 15, 2009.  The adoption of this topic had no impact on the Company’s financial position or results of operation.

In April 2009, the FASB issued additional guidance under ASC Topic 820, “Fair Value Measurements and Disclosures” (previously reported as FASB Staff Position No. FAS 157-4).   Topic 820 provides additional guidance for estimating the fair value of an asset or liability when the volume and level of activity for the asset or liability have significantly decreased, and identifying circumstances in which a transaction may not be orderly.  The adoption of this topic became effective for all interim and annual reporting periods ending after June 15, 2009.  The adoption of the additional guidance provided by Topic 820 did not have any material impact on the Company’s financial position or results of operation.

In April 2009, the FASB issued an amendment to ASC Topic 320, “Investments – Debt and Equity” which amends the guidance in regard to other-than-temporary impairments on debt and equity securities in the financial statements.  Topic 320 also requires additional disclosures in the financial statements that enable users to understand the types of debt and equity securities held, including those investments in an unrealized loss position for which an other-than-temporary impairment has or has not been recognized.  The adoption of the amendment to Topic 320 became effective for all interim and annual reporting periods ending after June 15, 2009.  The adoption of this amended topic did not have any material impact on the Company’s financial position or results of operation.

In May 2009, the FASB issued ASC Topic 855, “Subsequent Events”.  The statement establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued.  Topic 855 became effective June 15, 2009 for all subsequent reporting periods.  The adoption of Topic 855 did not have any material impact on the Company’s financial position or results of operation.

In June 2009, the FASB issued Accounting Standards Update (“ASU”) 2009-01, “The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles”.  This update identifies the sources of accounting principles and the framework for selecting the principles used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles (“GAAP”) in the United States.  This update is effective for financial statements issued for interim and annual periods ending after September 15, 2009.  The adoption of ASU 2009-01 did not have any material impact on the Company’s financial position or results of operation.

 
- 29-


In August 2009, the FASB issued ASU 2009-05, which is an update to Topic 820, “Fair Value Measurements and Disclosures”.  The update provides clarification in regard to the estimation of the fair value of a liability.  In addition, it also clarifies that both a quoted price in an active market for the identical liability at the measurement date and the quoted price for the identical liability when traded as an asset in an active market when no adjustments to the quoted price of the asset are required are Level 1 fair value measurements.  This update became effective for all interim and annual reporting periods ending after August 31, 2009.  The adoption of ASU 2009-05 did not have a material impact on the Company’s financial position or results of operation.

In January 2010, the FASB issued ASU 2010-06, which is an update to Topic 820, “Fair Value Measurement and Disclosures”.  This update establishes further disclosure requirements regarding transfers in and out of levels 1 and 2, and activity in level 3 fair value measurements.  The update also provides clarification as to the level of disaggregation for each class of assets and liabilities, requires disclosures about inputs and valuation techniques, and also includes conforming amendments to the guidance on employers’ disclosures about postretirement benefit plan assets.  ASU 2010-06 will be effective for all interim and annual reporting periods beginning after December 15, 2010.  ASU 2010-06 is not expected to have a material impact on the Company’s financial position or results of operation.

In February 2010, the FASB issued ASU 2010-09, which is an update to Topic 855, “Subsequent Events”.  This update clarifies the date through which the Company is required to evaluate subsequent events.  SEC filers will be required to evaluate subsequent events through the date that the financial statements are issued.  ASU 2010-09 was effective upon issuance, and will not have a material impact on the Company’s operations, financial condition or liquidity.

In December 2010, the FASB issued ASU 2010-28, which is an update to Topic 350, “Intangibles – Goodwill and Other”.  This update provides additional guidance with regard to performing goodwill impairment testing for reporting units with zero or negative carrying amounts.  ASU 2010-28 is effective for all interim and annual reporting periods beginning after December 15, 2010.  ASU 2010-28 is not expected to have a material impact on the Company’s operations, financial condition or liquidity.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

The Company’s financial statements (See Item 15) record the Company’s investments under the “mark to market” method (i.e., at date-of-statement market value).  The investments are, categorically listed, in “Common Stock”, “Mutual Funds”, “Other Equity”, “Preferred Stock”, “Government Obligations” and “Corporate Obligations” (which, primarily, are intended to be held to maturity).  $746,769 of the Company’s $7,797,899 portfolio of investments (as at Nov. 30, 2010) is invested in the ”Common Stock” and “Other Equity” category, and $2,591,562 is invested in Preferred Stock holdings.  The Company does not take positions or engage in transactions in risk-sensitive market instruments in any substantial degree, nor as defined by SEC rules and instructions, however due to current securities market conditions, the Company cannot ascertain the risk of any future change in the market value of its’ investments.

 
- 30-


Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The Financial Statements are listed under Item 15 in this Form 10-K.  The following financial data is a summary of the quarterly results of operations (unaudited) during and for the years ended November 30, 2010 and 2009:

   
Three Months Ended
 
Fiscal 2010
 
Feb. 28
   
May 31
   
Aug. 31
   
Nov. 30
 
                         
Net Sales
  $ 13,091,177     $ 14,708,108     $ 12,490,391     $ 10,055,537  
Total Revenue
    13,198,285       14,855,217       12,596,400       10,161,740  
                                 
Cost of Products Sold
    5,031,100       6,119,823       6,006,187       4,650,899  
Gross Profit
    8,060,077       8,588,285       6,484,204       5,404,638  
                                 
Net Income (Loss)
  $ 541,554     $ (910,589 )   $ (598,225 )   $ (697,500 )
                                 
Earnings (Loss) Per Share:
                               
Basic
  $ 0.08     $ (0.13 )   $ (0.08 )   $ (0.10 )
Diluted
  $ 0.08     $ (0.13 )   $ (0.08 )   $ (0.10 )


   
Three Months Ended
 
Fiscal 2009
 
Feb. 28
   
May 31
   
Aug. 31
   
Nov. 30
 
                         
Net Sales
  $ 14,758,850     $ 14,609,686     $ 15,139,754     $ 12,493,709  
Total Revenue
    14,944,466       14,748,329       15,344,595       12,634,774  
                                 
Cost of Products Sold
    5,616,212       5,527,838       5,616,335       5,090,190  
Gross Profit
    9,142,638       9,081,848       9,523,419       7,403,519  
                                 
Net Income
  $ 124,366     $ 694,136     $ 1,599,346     $ 1,013,796  
                                 
Earnings Per Share:
                               
Basic
  $ 0.02     $ 0.10     $ 0.23     $ 0.14  
Diluted
  $ 0.02     $ 0.10     $ 0.23     $ 0.14  

 
- 31-


Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

The Company did not change its accountants within the twenty-four months prior to the date of the most recent financial statements (nor since), and had no reported disagreement with its accountants on any matter of accounting principles or practices.

Item 9A. CONTROLS AND PROCEDURES

Under Section 404 of the Sarbanes-Oxley Act of 2002, The Company’s fiscal 2010 annual report is required to be accompanied by a “Section 404 Formal Report” by management on the effectiveness of internal controls over financial reporting.  The Company has engaged the services of CBIZ Risk & Advisory Services, LLC to assist in the development and implementation of procedures to determine and test the effectiveness of the Company’s internal controls over financial reporting. The Company’s officers are continually working to evaluate and confirm that the Company’s data processing software systems and other procedures are effective and that the information created by the Company’s systems adequately confirm the validity of the information upon which the Company relies.

The Company continually takes a thorough review of the effectiveness of its internal controls and procedures, including financial reporting.  It is working to strengthen all of its procedures wherever necessary.

An evaluation was performed under the supervision of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this report. Based on that evaluation, the Company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that, as of November 30, 2010, the Company’s disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Notwithstanding the foregoing, there can be no assurance that the Company’s disclosure controls and procedures will detect or uncover all failures of persons within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

 
- 32-


This annual report does not include an attestation report of the Company's independent registered public accounting firm regarding internal control over financial reporting.  Management's report was not subject to attestation by the Company's independent registered public accounting firm pursuant to rules of the SEC that pertain to smaller reporting companies, and permit the Company to provide only management's report in this annual report.

Management’s Report on Internal Control Over Financial Reporting

Under Section 404 of the Sarbanes-Oxley Act of 2002, our management, including our Chief Executive Officer and Chief Financial Officer, are required to assess the effectiveness of the Company’s internal control over financial reporting as of November 30, 2010 and report, based on that assessment, whether the Company’s internal controls over financial reporting are effective.

Management of the Company is responsible for establishing and maintaining adequate internal controls over financial reporting, as defined in Rules 13a-15(f) or 15d-15(f) under the Securities Exchange Act of 1934.  The Company’s internal control over reporting is designed to provide reasonable assurance regarding the reliability of the Company’s financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Internal control over reporting, because of its inherent limitations, may not prevent or detect misstatements.  Projections of any evaluation of effectiveness for future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

The Company’s management has assessed the effectiveness of its internal control over financial reporting as of November 30, 2010 using the criteria as set forth in Internal Control – Integrated Framework by the Committee of Sponsoring Organizations of the Treadway Commission.  The Company’s assessment included documenting, evaluating and testing of the design and operating effectiveness of its internal control over financial reporting.  Management of the Company has reviewed the results with the Audit Committee of the Board of Directors.

 
- 33-


Based on the Company’s assessment, management has concluded that, as of November 30, 2010, the Company’s internal control over financial reporting was effective.

/s/ DUNNAN EDELL
 
Dunnan Edell, Chief Executive Officer
   
/s/ STEPHEN A. HEIT
 
Stephen A. Heit, Chief Financial Officer

ITEM 9B.  OTHER INFORMATION

None

 
- 34-


PART III

Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

We have a code of ethics that applies to the Chairman of the Board, Directors, Officers and Employees, including our Chief Executive Officer and Chief Financial Officer.  You can find our code of ethics in Exhibit 14.

The Executive Officers and Directors of the Company are as follows:

NAME
 
POSITION
 
YEAR OF FIRST COMPANY SERVICE
         
Ira W. Berman
 
Chairman of the Board of Directors (1)
 
1983
         
David Edell
 
Director (2)
 
1983
         
Stanley Kreitman
 
Director
 
1996
         
Jack Polak
 
Director
 
1983
         
Robert Lage
 
Director
 
2003
         
James Mastrian
 
Director
 
2009
         
Dunnan Edell
 
Chief Executive Officer, President and Director (3)
 
1984
         
Stephen Heit
 
Executive Vice President and Chief Financial Officer
 
2005
         
Drew Edell
 
Executive Vice President-Product Development and Production, Corporate Secretary (4)
 
1983
         
John Bingman
 
Vice President and Treasurer
 
1986

 
(1)
Ira Berman was also Secretary and Executive Vice President until November 30, 2010.
 
(2)
David Edell was also Chief Executive Officer until November 30, 2010.
 
(3)
Dunnan Edell was also Chief Operating Officer until November 30, 2010 and became Chief Executive Officer, effective December 1, 2010.
 
(4)
Drew Edell became Secretary effective December 1, 2010.

 
- 35-


Ira W. Berman, age 79, is the Chairman of the Board of Directors.  Mr. Berman is an attorney who has been engaged in the practice of law since 1955.  He received a Bachelor of Arts Degree (1953) and Bachelor of Law Degree (1955) from Cornell University, and is a member of the American Bar Association.  Mr. Berman was also Secretary and Executive Vice President until November 30, 2010, and now serves as a consultant to the Company for a five year term that commenced January 1, 2011.

David Edell, age 78, is a director of the Company, and was the Company's Chief Executive Officer until November 30, 2010.  He now serves as a consultant to the Company for a five year term that commenced January 1, 2011.  Prior to his association with the Company, he was a marketing and financial consultant; and, by 1983, he had extensive experience in the health and beauty aids field as an executive director and/or officer of Hazel Bishop, Lanolin Plus and Vitamin Corporation of America.  In 1954, David Edell received a Bachelor of Arts degree from Syracuse University.

Stanley Kreitman, age 78, is a director of the Company. He has been Vice Chairman of Manhattan Associates an equity investment firm since 1994.  He is a director of Medallion Financial Corp. (NASDAQ), Capital Lease Financial Corp. (NYSE), and KSW Corp.  He also serves as a director of the New York City Board of Corrections, Nassau County Crime Stoppers, and serves on the board of the Police Athletic League.  From 1975 to 1993 he was President of United States Banknote Corp. (NYSE) a securities printer.

Jack Polak, age 98, is a director of the Company.  He has been a private investment consultant and a banker since April 1982.  He is a certified Dutch Tax Consultant and a member of The Netherlands Federation of Certified Tax Consultants.  He was knighted on his 80th birthday by Queen Beatrix of the Netherlands for his untiring efforts on behalf of the Anne Frank Center USA for which he is still actively working as the “Chairman-Emeritus.”  On May 23, 2004, Hofstra University in Long Island, NY awarded him with an honorary doctorate in humane letters.

Robert Lage, age 74, is a director of the Company, and a retired CPA.  He was a partner at Pricewaterhouse Coopers Management Consulting Service prior to his retirement in 1997.  He has been engaged in the practice of public accounting and management consulting since 1959.  He received a BBA from Bernard Baruch College of the City University of New York in 1958.

James P. Mastrian, age 68, is a director of the Company.  He retired from the Rite Aid Corp. in August 2008.  He was the special advisor to the Chairman and Chief Executive Officer.  Prior to that, he was the Chief Operating Officer of Rite Aid Corp. from October 2005 to August 2007. He had been Senior Executive Vice President, Marketing, Logistics and Pharmacy Services from November 2002 to October 2005, and was Senior Executive Vice President, Marketing and Logistics of Rite Aid from October 2000 until November 2002. Prior to that he was Executive Vice President, Marketing from November 1999 to October 2000. Mr. Mastrian was also Executive Vice President, Category Management of Rite Aid from July 1998 to November 1999. Mr. Mastrian was Senior Executive Vice President, Merchandising and Marketing of OfficeMax, Inc. from June 1997 to July 1998 and Executive Vice President, Marketing of Revco D.S., Inc. from July 1994 to June 1997, and served in other positions from September 1990.  Mr. Mastrian also serves on the National Board of the Boys Hope Girls Hope, an international educational and residential program for academically capable abused, neglected and abandoned children.  Mr. Mastrian received a B.S. Pharmacy from the University of Pittsburgh in 1965.

 
- 36-


Dunnan Edell is the 55 year-old son of David Edell.  He is a graduate of George Washington University.  Mr. Edell was appointed Chief Executive Officer and President of the Company, effective December 1, 2010.  He has been a director since 1994, and in fiscal 2003, he was promoted to position of President of the Company and Chief Operating Officer.  He joined the Company in 1984 and was appointed Divisional Vice-President in 1986.  He was employed by Alleghany Pharmacal Corporation from 1982 to 1984 and by Hazel Bishop from 1977 to 1981.

Stephen Heit, age 56 joined CCA in May 2005 as Executive Vice President – Operations, and was appointed Chief Financial Officer in March 2006. Prior to that he was Vice President – Business Strategies for Del Laboratories, Inc., a consumer products company that was listed on the American stock exchange, from 2003 to 2005.  Mr. Heit served as President of AM Cosmetics, Inc. from 2001 to 2003, as Chief Financial Officer from 1998 to 2003, and Corporate Secretary to the Board of Directors from 1999 to 2003.  From 1986 to 1997 he was the Chief Financial Officer of Pavion Limited, and also served on the Board of Directors.  He also served as a Director of Loeb House, Inc., a non-profit organization serving mentally handicapped adults from 1987 to 1995, and Director of Nyack Hospital Foundation from 1993 to 1995.  He received a Bachelor of Science from Dominican College in 1976, with additional graduate work in Professional Accounting at Fordham University from 1976 – 1978, and is a MBA Candidate at the University of Connecticut Graduate Business School.

Drew Edell, the 53 year-old son of David Edell, is a graduate of Pratt Institute, where he received a Bachelor's degree in Industrial Design. Mr. Edell has been Executive Vice President – Product Development and Production, and became Secretary, effective December 1, 2010.  He joined the Company in 1983, and in 1985, he was appointed Vice President of Product Development and Production.

John Bingman, age 59, received a Bachelor of Science degree from Farleigh Dickenson University in 1973.  He worked as a Certified Public Accountant who practiced with the New Jersey accounting firm of Zarrow, Zarrow & Klein from 1976 to 1986.

Committees of the Board of Directors

The Board of Directors has established three committees.  The audit committee is comprised of Robert Lage, who serves as its’ Chairman, Stanley Kreitman, and Jack Polak.  Robert Lage, Chairman of the Committee, qualifies as a “financial expert” as defined by the United States Securities and Exchange Commission in Instruction 1 to proposed Item 309 of Regulation S-K, which is set forth in the SEC Release No. 34-46701 dated October 22, 2003.  Robert Lage, Stanley Kreitman, and Jack Polak are “independent” as that term is used in Section 10(m)(3) of the Exchange Act.  The compensation committee is comprised of Stanley Kreitman, Jack Polak, James P. Mastrian and Robert Lage.  Each member of the compensation committee is “independent”.  The investment committee is comprised of Ira Berman, Stanley Kreitman, Bob Lage and Jack Polak.

 
- 37-


Code of Ethics

The Company had adopted Standards of Business Conduct, which apply to all employees of the Company, including the Chief Executive Officer and Chief Financial Officer.  A copy of the Standard of Business Conduct may be found in the investor section of the Company’s web site, www.ccaindustries.com, under Corporate Governance.

Item 11. EXECUTIVE COMPENSATION

i. Summary Compensation Table

The following table summarizes compensation earned in the 2010, 2009 and 2008 fiscal years by the Chief Executive Officer and Chief Financial Officer (the "Named Officers"), the three most highly compensated executive officers other than the Named Officers, and the non-executive officer who would be among the three most highly compensated employees of the Company other than the Named Officers.

   
Annual Compensation
   
Long-Term Compensation
 
                   
All Other Annual Compen-
   
Number
of Shares Covered by Stock Options
   
Other Long-Term Compen-
 
Name and Principal Position
 
Year
 
Salary
   
Bonus(1)
   
sation(2)
   
Granted(3)
   
sation
 
David Edell,
 
2010
  $ 930,042     $ 350,776     $ 44,888       ---       0 (4)
Former Chief
 
2009
    878,354       513,328       43,652       ---       0 (4)
Executive Officer
 
2008
    812,700       422,285       43,639       ---       0 (4)
                                             
Ira W. Berman,
 
2010
  $ 930,042     $ 350,776     $ 47,811       ---       0 (4)
Former Secretary and
 
2009
    878,354       513,328       45,552       ---       0 (4)
Executive Vice President
 
2008
    812,700       422,285       45,443       ---       0 (4)
                                             
Dunnan Edell,
 
2010
  $ 350,000     $ 64,000     $ 17,977       ---       0  
President, Chief
 
2009
    350,000       96,000       17,909       ---       0  
Executive Officer
 
2008
    343,269       96,000       16,632       ---       0  
                                             
Stephen Heit
 
2010
  $ 250,000     $ 23,333     $ 12,709       ---       0  
Executive Vice President,
 
2009
    250,000       35,000       10,370       ---       0  
Chief Financial Officer
 
2008
    234,615       24,000       9,093       ---       0  
                                             
Drew Edell
 
2010
  $ 275,000     $ 32,000     $ 17,140       ---       0  
Executive Vice
 
2009
    275,000       48,000       12,620       ---       0  
President Product
 
2008
    269,711       48,000       11,442       ---       0  
Development &
                                           
Production, Secretary
                                           
                                             
Jon Denis
 
2010
  $ 325,000     $ 10,000     $ 11,979       ---       0  
Senior Executive
 
2009
    325,000       15,000       13,252       ---       0  
Vice President – Sales
 
2008
    318,750       6,250       10,578       ---       0  

 
- 38-


 
(1)
Bonus amounts represent amounts earned in each respective fiscal year, not necessarily paid in each year.
 
(2)
Includes the personal use value of Company leased automobiles, the value of Company-provided life insurance, and health insurance that is made available to all employees.  The Employment Agreement of Edell/Berman expired on December 31, 2010.  Please see Item. 11, section v. - Employment Contracts/Compensation Program for further information regarding the compensation of David Edell and Ira Berman.
 
(3)
Information in respect of stock option plans appears below in the sub-topic, Employment Contracts/Executive Compensation Program.  For information in regard to stock appreciation rights, refer to Note 9 of the financial statements.
 
(4)
The Employment Agreements of Edell/Berman provides that in the event of death within the employment or consulting periods, the Company is obligated for two successive years to pay the executive’s estate an amount equal to the annual base salary and bonus.

 
ii.
Fiscal 2010 Option Grants and Option Exercises, Year-End Option Valuation, Option Repricing

On September 27, 2007, the Company granted stock appreciation rights for 10,000 shares to its Executive Vice President of Sales, at $9.40 per share, which was the price of the stock on the day of the grant.  The stock appreciation rights granted did not vest until two years after the grant date and expire five years after the grant date.  Upon exercise, the value would be computed by the difference in the share price of the stock on the date of grant ($9.40) and the price on the exercise date.  The stock appreciation rights would be exercisable to purchase the Company’s common stock at the price of the stock on the date of exercise.

 
- 39-


There were no stock options granted or options exercised during fiscal 2010.  All outstanding options expired during fiscal 2009.

 
iii.
Compensation of Directors and Committees of the Board

Director
 
Year Ended Nov. 30, 2010
 
Stanley Kreitman
  $ 17,500  
Robert Lage
    47,500  
James Mastrian
    17,500  
Jack Polak
    17,500  
         
         
Total
  $ 100,000  

Each outside director was paid $2,500 for a conference call meeting and $5,000 per meeting for attendance at board meetings in fiscal 2010 (without additional compensation for committee meetings, other than as noted below). The full Board of Directors met three times in fiscal 2010, for an aggregate compensation of $60,000, not including Mr. Lage’s additional compensation of $30,000 as chairman of the audit committee. The Board of Directors participated in one conference call in May 2010, for an aggregate compensation of $10,000.  No stock options were awarded.

 
iv.
Executive Compensation Principles - Compensation Committee

The Company's Executive Compensation Program is based on guiding principles designed to align executive compensation with Company values and objectives, business strategy, management initiatives, and financial performance.  In applying these principles the Compensation Committee of the Board of Directors, comprised of Stanley Kreitman, Jack Polak, James P. Mastrian and Robert Lage, has established a program to:

Reward executives for long-term strategic management and the enhancement of shareholder value.

Integrate compensation programs with both the Company's annual and long-term strategic planning.

Support a performance-oriented environment that rewards performance not only with respect to Company goals but also Company performance as compared to industry performance levels.

The Compensation Committee has a charter, which was published with the proxy statement for the 2010 annual meeting of shareholders.  Compensation, including annual bonus amounts, for the executive officers named in the Summary Compensation Table (other than David Edell and Ira Berman, whose compensation and bonus were determined in accordance with their employment agreement) are recommended by Dunnan Edell, Chief Executive Officer, and approved by the Compensation Committee.

 
- 40-


 
v.
Employment Contracts/Compensation Program

The total compensation program consists of both cash and equity based compensation.  The Compensation Committee (the "Committee") determines the level of salary and bonuses, if any, for key executive officers of the Company.  The Committee determines the salary or salary range based upon competitive norms.  Actual salary changes are based upon performance, and bonuses were awarded by the Committee in consideration of the employee's performance during the 2010 fiscal year.

The Company had executed Employment Contracts with its former Chief Executive Officer, David Edell, and its Chairman of the Board and former Secretary, Ira W. Berman. Mr. Berman remains as Chairman of the Board, and both Mr. Edell and Mr. Berman remain as directors of the Company.  The contracts for both are exactly the same.  Employment under the contracts expired on December 31, 2010.  The contracts provided for a base salary which commenced in 1994 in the amount of $300,000 (plus a bonus of 20% of the base salary), with a year-to-year CPI of 6% increase, plus 2.5% of the Company’s pre-tax income plus depreciation and amortization.  The 2.5% measure in the bonus provision of the Edell/Berman contracts was amended on November 3, 1998 so as to calculate it against income before income taxes, plus depreciation, amortization and expenditures for media and cooperative advertising in excess of $8,000,000.  On May 24, 2001, the contract was amended increasing the base salary then in effect by $100,000 per annum (See Item 11, Summary Compensation Table).  Upon expiration of the employment term on December 31, 2010, Mr. Edell and Mr. Berman became consultants to the Company for an ensuing five year term in accordance with the provisions of the agreement.  For the consulting services provided, Mr. Edell and Mr. Berman will be paid fifty percent (50%) of their annual base salary plus bonus that they received in 2010.  Under the provisions of the employment contracts, this amount will increase six percent (6%) per year for each successive year of the consulting term.  Mr. Edell and Mr. Berman are also entitled to all benefits that they had previously received as employees for the consulting term.  The contracts also provide that in the event of the death of Edell/Berman within the employment or consulting periods, the Company is obligated for two successive years to pay the executive’s estate an amount equal to their total compensation as that time.  The Company, per the Employment Agreement, pays for life insurance policies owned by Edell/Berman with a face value of $750,000 each.  Edell/Berman are entitled to have the Company pay for a complete physical examination and reimbursement of up to $5,000 of medical expenses during each benefit year.

David Edell’s sons, Dunnan Edell and Drew Edell have five-year employment contracts in the amounts of $270,000 and $200,000 respectively, which were to expire on November 30, 2007.  On February 10, 2006, the Board of Directors extended the contracts for Dunnan Edell and Drew Edell to December 31, 2010.  On July 1 2003, Dunnan Edell’s salary was increased to $300,000, and on January 5, 2004, Drew Edell’s salary was increased to $225,000 and in 2005, it was increased to $250,000.  On May 17, 2007, the employment contracts for Dunnan Edell and Drew Edell were extended to November 30, 2012 (See Item 11, Summary Compensation Table).  Dunnan Edell’s salary was increased to $350,000 and Drew Edell’s salary was increased to $275,000.  Dunnan Edell was appointed President and Chief Executive Officer of the Company, effective December 1, 2010.  He also serves as a director of the Company.  Prior to his appointment, Mr. Edell was President and Chief Operating Officer.  Drew Edell serves as Executive Vice President of Product Development and Production.  He was appointed Secretary, effective December 1, 2010.

 
- 41-


 
vi.
Stock Option Plans

Long-term incentives are provided through the issuance of stock options.

The 1984 Stock Option Plan covered 1,500,000 shares of its Common Stock, and the 1986 Stock Option Plan covered 1,500,000 shares of its Common Stock.  On July 9, 2003, the Company’s Stock Option Plan was approved by the shareholders authorizing the issuance of options to issue up to 1,000,000 shares of common stock.

The Company's 2003 Stock Option Plan covers 1,000,000 shares of its Common Stock.

The 2003 Option Plan provides (as had the 1984, 1986 and the 1994 plans) for the granting of two (2) types of options: "Incentive Stock Options" and "Nonqualified Stock Options".  The Incentive Stock Options (but not the Nonqualified Stock Options) are intended to qualify as "Incentive Stock Options" as defined in Section 422(a) of The Internal Revenue Code.  The Plans are not qualified under Section 401(a) of the Code, nor subject to the provisions of the Employee Retirement Income Security Act of 1974.

Options may be granted under the Options Plans to employees (including officers and directors who are also employees) and consultants of the Company provided, however, that Incentive Stock Options may not be granted to any non-employee director or consultant.

Option Plans are administered and interpreted by the Board of Directors.  (Where issuance to a Board member is under consideration, that member must abstain.)  The Board has the power, subject to plan provisions, to determine the persons to whom and the dates on which options will be granted, the number of shares subject to each option, the time or times during the term of each when options may be exercised, and other terms.  The Board has the power to delegate administration to a committee of not less than two (2) Board members, each of whom must be disinterested within the meaning of Rule 16b-3 under the Securities Exchange Act, and ineligible to participate in the option plan or in any other stock purchase, option or appreciation right under plan of the Company or any affiliate.  Members of the Board receive no compensation for their services in connection with the administration of option plans.

Option Plans permit the exercise of options for cash, other property acceptable to the Board or pursuant to a deferred payment arrangement.  The 1994 Plan specifically authorizes that payment may be made for stock issuable upon exercise by tender of Common Stock of the Company; and the Executive Committee is authorized to make loans to option exercisers, other than officers, to finance optionee tax-consequences in respect of option exercise, but such loans must be personally guaranteed and secured by the issued stock.

The maximum term of each option is ten (10) years.  No option granted is transferable by the optionee other than upon death.

On June 15, 2005, the shareholders approved an amended and Restated Stock Option Plan amending the 2003 Stock Option Plan.

 
- 42-


The Plan provides that the stock option committee may make awards in the form of (a) incentive stock options, (b) non-qualified stock options, (c) stock appreciation rights, (d) restricted stock, and (e) performance shares.

One new award was made by the committee in fiscal 2007 (See Executive Compensation in Fiscal 2007 Option Grants).

Under the plans, options will terminate three (3) months after the optionee ceases to be employed by the Company or a parent or subsidiary of the Company unless (i) the termination of employment is due to such person's permanent and total disability, in which case the option may, but need not, provide that it may be exercised at any time within one (1) year of such termination (to the extent the option was vested at the time of such termination); or (ii) the optionee dies while employed by the Company or a parent or subsidiary of the Company or within three (3) months after termination of such employment, in which case the option may, but need not provide that it may be exercised (to the extent the option was vested at the time of the optionee's death) within eighteen (18) months of the optionee's death by the person or persons to whom the rights under such option pass by will or by the laws of descent or distribution; or (iii) the option by its terms specifically provides otherwise.

The exercise price of all nonqualified stock options must be at least equal to eighty-five percent (85%) of the fair market value of the underlying stock on the date of grant.  The exercise price of all Incentive Stock Options must be at least equal to the fair market value of the underlying stock on the date of grant.  The aggregate fair market value of stock of the Company  (determined at the date of the option grant) for which any employee may be granted Incentive Stock Options in any calendar year may not exceed $100,000, plus certain carryover allowances.  The exercise price of an Incentive Stock Option granted to any participant who owns stock possessing more than ten percent (10%) of the voting rights of the Company's outstanding capital stock must be at least one hundred-ten percent (110%) of the fair market value on the date of grant. As of November 30, 2010, there were no outstanding stock options.

The Company has adopted Stock Appreciation Rights incentives and Restricted Stock grants in the 2005 Amended Stock Option Plan.  No such grants were issued in fiscal 2010.  All of the terms and conditions of the Plan were included in the June 15, 2005 Proxy, which Plan was approved by the shareholders at the annual meeting.  The Proxy was incorporated by reference to the 10K Annual Report for fiscal 2005.

 
- 43-


 
vii.
Performance Graph

Set forth below is a line graph comparing cumulative total shareholder return on the Company's Common Stock, with the cumulative total return of companies in the Dow Jones US Index and the cumulative total return of Dow Jones's Personal Products Index.

CCA Industries - ASE

 
Copyright© 2010 Dow Jones & Company. All rights reserved.
                                     
      11/05       11/06       11/07       11/08       11/09       11/10  
                                                 
CCA Industries, Inc.
    100.00       144.41       124.28       49.61       62.60       83.39  
Dow Jones US
    100.00       114.42       123.47       75.77       96.73       108.50  
Dow Jones US Personal Products
    100.00       119.92       143.12       110.52       147.68       146.87  

 
- 44-


Item 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

The following table sets forth certain information regarding the beneficial ownership of the Company's Common Stock and/or Class A Common Stock as of November 30, 2010 by (i) all those known by the Company to be owners of more than five percent of the outstanding shares of Common Stock or Class A Common Stock; (ii) each officer and director; and (iii) all officers and directors as a group.

Unless otherwise indicated, each of the shareholders has sole voting and investment power with respect to the shares owned (subject to community property laws, where applicable), and is beneficial owner of them.

   
Number of Shares Owned (1):
         
Ownership, As A Percentage of All Shares Out-Standing/Assuming Option
 
Name and Address
 
Common Stock
   
Class A (2)
   
“Option
Shares” (1)
   
Share
Exercise (1)
 
David Edell
                       
c/o CCA Industries, Inc.
    146,609       484,615       ---       8.9 %
200 Murray Hill Parkway
                               
East Rutherford, NJ 07073
                               
                                 
Ira W. Berman
                               
c/o CCA Industries, Inc.
    160,533       483,087       ---       9.1 %
                                 
Stanley Kreitman
                               
c/o CCA Industries, Inc.
    15,000       ---       ---       0.2 %
                                 
Robert Lage
                               
c/o CCA Industries, Inc.
    ---       ---       ---       0.0 %
                                 
James P. Mastrian
                               
c/o CCA Industries, Inc.
    ---       ---       ---       0.0 %
                                 
Jack Polak
                               
c/o CCA Industries, Inc.
    53,254       ---       ---       0.8 %
                                 
Dunnan Edell
                               
c/o CCA Industries, Inc.
    97,158       ---       ---       1.4 %
                                 
Drew Edell
c/o CCA Industries, Inc.
    98,108       ---       ---       1.4 %
                                 
John Bingman
c/o CCA Industries, Inc.
    ---       ---       ---       0.0 %
                                 
Stephen A. Heit
                               
c/o CCA Industries, Inc.
    2,279       ---       ---       0.0 %
                                 
All Officers and Directors as a group (10 persons)
    572,941       967,702       ---       21.8 %

 
- 45-


_______________________

 
(1)
The number of “Option Shares” represents the number of shares that could be purchased by, and upon exercise of unexercised options, exercisable within 90 days; and the percentage ownership figure denominated “Assuming Option Share Exercise” assumes, per person, that unexercised options have been exercised and, thus, that subject shares have been purchased and are actually owned.  In turn, the “assumed” percentage ownership figure is measured, for each owner, as if each had exercised such options, and purchased subject ‘option shares,’ and thus increased total shares actually outstanding, but that no other option owner had ‘exercised and purchased’.

 
(2)
David Edell and Ira Berman own 100% of the outstanding shares of Class A Common Stock. Messrs. David Edell, Dunnan Edell, and Ira Berman are officers and directors.  Messrs. Stephen Heit, John Bingman and Drew Edell are officers.  Messrs. Lage, Mastrian, Kreitman and Polak are independent, outside directors.

There were no other shareholders who owned more than five percent of the outstanding Common Stock or Class A Common Stock of the Company.

 
- 46-


Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The Company did not purchase any shares of common stock from officers, directors or affiliates in fiscal 2010.

During fiscal 2010, several related parties provided services to the Company, which were deemed immaterial to the financial statements.

The independent directors of the Company are: Robert Lage, Stanley Kreitman, Jack Polak and James P. Mastrian.  There were no transactions, relationships or arrangements not disclosed in this item that would need to be considered by the Company’s board of directors in determining the director’s independence.

Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

KGS LLP (“KGS”) served as the Company’s independent registered public accounting firm for 2010 and 2009.  The services performed by KGS in this capacity included conducting an audit in accordance with generally accepted auditing standards of, and expressing an opinion on, the Company’s consolidated financial statements.

Audit Fees

KGS’s fees for professional services rendered in connection with the audit and review of Forms 10-K and all other SEC regulatory filings were $320,000 for the 2010 fiscal year and $340,000 for the 2009 fiscal year.  The Company has paid and is current on all billed fees.

Audit Related Fees

Audit related fees billed in Fiscal 2010 and 2009 by KGS were $2,500 and $4,000 respectively.  Audit related fees consist primarily of fees billed for professional services rendered by KGS for accounting consultations and readiness consultations for Section 404 of the Sarbanes Oxley Act of 2002.

Tax Fees

KGS’s fees for professional services rendered in connection with Federal and State tax return preparation and other tax matters for the 2010 and 2009 fiscal years were $35,000 and $55,000, respectively.

All Other Fees

All other fees of $0 and $0 billed in Fiscal years 2010 and 2009, respectively, represent fees for miscellaneous services other than those described above.

 
- 47-


Engagements Subject to Approval

Under its charter, the Audit Committee must pre-approve all subsequent engagements of our independent registered public accounting firm unless an exception to such pre-approval exists under the Securities Exchange Act of 1934 or the rules of the Securities and Exchange Commission.  Each year, the independent registered public accounting firm’s retention to audit our financial statements, including the associated fee, is approved by the committee before the filing of the preceding year’s annual report on form 10-K.  At the beginning of the fiscal year, the Audit Committee will evaluate other known potential engagements of the independent registered public accounting firm, including the scope of the work proposed to be performed and the proposed fees, and approve or reject each service, taking into account whether the services are permissible under applicable law and the possible impact of each non-audit service on the independent registered public accounting firm’s independence from management.  At each subsequent committee meeting, the committee will receive updates on the services actually provided by the independent registered public accounting firm, and management may present additional services for approval.  The committee has delegated to the Chairman of the committee the authority to evaluate and approve engagements on behalf of the committee in the event that a need arises for pre-approval between committee meetings.  If the Chairman so approves any such engagements, he will report that approval to the full committee at the next committee meeting.

 
- 48-


PART IV

Item 15. EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES AND REPORTS ON FORM 8-K

Financial Statements:

Table of Contents, Report of Independent Registered Public Accounting Firm, Consolidated Balance Sheets as of November 30, 2010 and 2009, Consolidated Statements of Operations for the years ended November 30, 2010, 2009 and 2008, Consolidated Statements of Comprehensive (Loss) Income for the years ended November 30, 2010, 2009 and 2008, Consolidated Statements of Shareholders' Equity for the years ended November 30, 2010, 2009 and 2008, Consolidated Statements of Cash Flows for the years ended November 30, 2010, 2009 and 2008, Notes to Consolidated Financial Statements.

Financial Statement Supplementary Information:

Schedule II: Valuation Accounts; Years Ended November 30, 2010, 2009 and 2008.

Exhibits:  All Exhibits are incorporated by reference.

(1)
The Indenture (and the Promissory note exhibited therewith) defining the rights of former shareholders who tendered Common Stock to the Company for its $2 per share, five- year, 6% debenture, is incorporated by reference to the filing of such documents with the Schedule TO filed with the SEC, on June 5, 2001.

(3)
The Company's Articles of Incorporation and Amendments thereof, and its By-Laws, are incorporated by reference to their filing with the Form 10-K/A filed April 5, 1995.  (Exhibit pages 000001-23).

(10.1)
The Following Material Contracts are incorporated by reference to their filing with the Form 10-K/A filed April 5, 1995: Amended and Restated Employment Agreements of 1994, with David Edell and Ira Berman; License Agreement made February 12, 1986 with Alleghany Pharmacal Corporation.

 
(10.2) The February 1999 Amendments to the Amended and Restated Employment Agreements of David Edell and Ira Berman (1994) are incorporated by reference to the 1998 10-K. (Exhibit pages 00001-00002).  The May 29, 2001 Amended and Restated Employment Agreements of David Edell and Ira Berman are incorporated by reference herein.

Previously filed as an exhibit to and incorporated by reference from the indicated report filed with the Securities and Exchange Commission:

 
(1)
The Company’s 2003 Stock Option Plan was filed with the 2003 Proxy and is incorporated by reference to this 10K.
 
 
- 49 -

 
 
(2)
The Company’s 2005 Amended and Restated Stock Option Plan and the 2005 Proxy are incorporated by reference herein.

The following reports were filed with the Securities and Exchange Commission during the three months ended November 30, 2010:

 
(1)
Form 8-K, filed on October 18, 2010, announcing that the Board of Directors had appointed Dunnan D. Edell as Chief Executive Officer and President of the Company, effective December 1, 2010, and that Drew Edell had been appointed Corporate Secretary effective on the same date.  It was also announced that the employment contracts of David Edell and Ira Berman will expire on December 31, 2010, and that pursuant to the terms of the contracts, they will become consultants to the Company for a period of five years, and will also continue to serve on the Board of Directors.

 
(2)
Form 10-Q, filed on October 15, 2010, for the quarter ended August 31, 2010

 
(3)
Form 8-K, filed on October 11, 2010, announcing that the Superior Court for the State of California, County of Los Angeles, Central Civil West, had entered a Final Order and Judgment in the case Denise Wally and Lauren Fleischer, etal. vs. CCA Industries, Inc.

(11)
Statement re Per Share Earnings (included in Item 15, Financial Statements).

(14) 
Code of Ethics for Chief Executive Officer and Senior Financial Officers are referenced.

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) included herein.

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) included herein.

Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350 included herein.

Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350 included herein.

Shareholders may obtain a copy of any exhibit not filed herewith by writing to CCA Industries, Inc., 200 Murray Hill Parkway, East Rutherford, New Jersey 07073.  Moreover, exhibits may be inspected and copied at prescribed rates at the Commission’s public reference facilities at Judiciary Plaza, 450 Fifth Street, NW, Washington, D.C. 20549; Jacob K. Javits Federal Building, 26 Federal Plaza, New York, New York 10278; and Northwestern Atrium Center, 500 West Madison Street, Suite 1400, Chicago, Illinois 60661-2511.  Copies of such materials may also be obtained by mail at prescribed rates from the Public Reference Branch of the Commission at 450 Fifth Street, N.W., Washington, D.C. 20549, and one is available at the Commission’s Internet website (http://www.sec.gov).

 
- 50 -


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report to be signed on its behalf by the undersigned thereunto duly authorized.

   
CCA INDUSTRIES, INC.
     
 
By:
/s/   DUNNAN D. EDELL
 
   
DUNNAN D. EDELL, President and Chief Executive Officer
     
 
Date:
February 28, 2011

 
- 51 -

 
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature
 
Title
 
Date
         
/s/   DUNNAN EDELL
 
Chief Executive Officer,
 
February 28, 2011
DUNNAN EDELL
 
President, Director
   
         
/s/   IRA BERMAN
 
Chairman of the Board
 
February 28, 2011
IRA W. BERMAN
 
of Directors
   
         
/s/   STEPHEN A. HEIT
 
Executive Vice President,
 
February 28, 2011
STEPHEN A. HEIT
 
Chief Financial Officer
   
         
/s/   DREW  EDELL
 
Executive Vice President,
 
February 28, 2011
DREW EDELL
 
Product Development and Production
   
         
/s/   DAVID EDELL
 
Director
 
February 28, 2011
DAVID EDELL
       
         
/s/   STANLEY KREITMAN
 
Director
 
February 28, 2011
STANLEY KREITMAN
       
         
/s/  ROBERT LAGE
 
Director
 
February 28, 2011
ROBERT LAGE
       
         
/s/   JACK POLAK
 
Director
 
February 28, 2011
JACK POLAK
       
         
/s/   JAMES P. MASTRIAN
 
Director
 
February 28, 2011
JAMES P. MASTRIAN
       

 
- 52 -


CCA INDUSTRIES, INC. AND SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS

NOVEMBER 30, 2010 AND 2009

 
- 53 -


C O N T E N T S

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
55
   
FINANCIAL STATEMENTS:
 
   
CONSOLIDATED BALANCE SHEETS
56 - 57
   
CONSOLIDATED STATEMENTS OF OPERATIONS
58
   
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
59
   
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
60
   
CONSOLIDATED STATEMENTS OF CASH FLOWS
61
   
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
62 - 96
   
SUPPLEMENTARY INFORMATION
 
   
SCHEDULE II – VALUATION ACCOUNTS
97
   
SIGNATURES
98 - 101

 
- 54 -


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders
CCA Industries, Inc.
East Rutherford, New Jersey

We have audited the consolidated balance sheets of CCA Industries, Inc. and Subsidiaries as of November 30, 2010 and 2009, and the related consolidated statements of operations, comprehensive (loss) income, shareholders’ equity and cash flows for each of the three fiscal years in the period ended November 30, 2010.  These consolidated financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of CCA Industries, Inc. and Subsidiaries as of November 30, 2010 and 2009, and the consolidated results of their operations and their cash flows for each of the three fiscal years in the period ended November 30, 2010 in conformity with accounting principles generally accepted in the United States of America.

Our audit was conducted for the purpose of forming an opinion on the basic financial statements taken as a whole.  The schedule titled “Schedule II – Valuation and Qualifying Accounts” is presented for purposes of additional analysis and is not a required part of the basic financial statements.  This schedule has been subjected to the auditing procedures applied in the audit of the basic financial statements and, in our opinion, is fairly stated in all material respects in relation to the basic financial statements taken as a whole.

/s/ KGS  LLP

February 28, 2011
Jericho, New York

 
- 55 -


CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

A S S E T S

   
NOVEMBER 30,
 
   
2010
   
2009
 
             
Current Assets
           
Cash and cash equivalents
  $ 8,064,255     $ 7,844,369  
Short-term investments and marketable securities (Notes 2 and 6)
    4,673,848       9,636,103  
Accounts receivable, net of allowances of $1,263,250 and $1,584,814, respectively
    5,990,010       7,613,273  
Inventories, net of reserve for inventory obsolescence of $1,372,798 and $760,001, respectively (Notes 2 and 3)
    9,077,234       8,327,277  
Insurance claim receivable
    361,639       ---  
Prepaid expenses and sundry receivables
    976,108       739,139  
Prepaid and refundable income taxes (Note 8)
    999,702       89,535  
Deferred income taxes (Note 8)
    1,999,174       1,193,745  
                 
Total Current Assets
    32,141,970       35,443,441  
                 
Property and equipment, net of accumulated depreciation and amortization (Notes 2 and 4)
    550,689       682,921  
                 
Intangible assets, net of accumulated amortization (Notes 2 and 5)
    673,580       697,506  
                 
Other assets
               
Marketable securities (Notes 2 and 6)
    3,124,051       2,900,035  
Other
    65,300       65,300  
                 
Total Other Assets
    3,189,351       2,965,335  
                 
Total Assets
  $ 36,555,590     $ 39,789,203  

See Notes to Consolidated Financial Statements.

 
- 56 -


CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

LIABILITIES AND SHAREHOLDERS' EQUITY

   
NOVEMBER 30,
 
   
2010
   
2009
 
             
Current Liabilities
           
Accounts payable and accrued liabilities (Note 10)
  $ 9,101,365     $ 8,775,676  
Capitalized lease obligations
    15,197       53,233  
Income taxes payable (Note 8)
    ---       147,153  
Dividends payable (Note 12)
    493,811       493,811  
                 
Total Current Liabilities
    9,610,373       9,469,873  
Deferred income tax liability (Note 8)
    118,717       76,929  
Capitalized lease obligations – long term
    8,149       22,553  
                 
Total  Liabilities
    9,737,239       9,569,355  
                 
Commitments and Contingencies (Note 12)
               
                 
Shareholders' Equity
               
Preferred stock, $1.00 par; authorized 20,000,000 shares; none issued
    ---       ---  
Common stock, $.01 par; authorized 15,000,000 shares; issued and outstanding 6,086,740 and 6,086,740 shares, respectively
    60,867       60,867  
Class A common stock, $.01 par; authorized 5,000,000 shares; issued and outstanding 967,702 and 967,702 shares, respectively
    9,677       9,677  
Additional paid-in capital
    2,329,049       2,329,049  
Retained earnings
    24,454,779       28,094,783  
Unrealized (losses) on marketable securities (Note 2)
    (36,021 )     (274,528 )
                 
Total Shareholders' Equity
    26,818,351       30,219,848  
                 
Total Liabilities and Shareholders' Equity
  $ 36,555,590     $ 39,789,203  

See Notes to Consolidated Financial Statements.

 
- 57 -


CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
 
   
Years Ended November 30,
 
   
2010
   
2009
   
2008
 
                   
Revenues
                 
Sales of health and beauty aid products, net
  $ 50,345,213     $ 57,001,999     $ 56,741,133  
Other income
    466,429       670,165       716,813  
                         
      50,811,642       57,672,164       57,457,946  
Costs and Expenses
                       
Cost of sales
    21,808,009       21,850,575       21,769,142  
Selling, general and  administrative expenses
    21,139,743       20,037,352       22,122,849  
Advertising, cooperative and  promotions
    7,493,282       9,667,446       10,466,740  
Research and development
    619,147       499,636       603,486  
(Benefit from) provision for doubtful accounts
    (130,192 )     (4,901 )     12,886  
Interest expense
    4,033       11,932       16,444  
                         
                         
Total
    50,934,022       52,062,040       54,991,547  
                         
Advertising Litigation Expense
    2,235,465       ---       ---  
                         
Total Costs and Expenses
    53,169,487       ---       ---  
                         
(Loss) Income before (Benefit) Provision for Income Taxes
    (2,357,845 )     5,610,124       2,466,399  
                         
(Benefit) Provision for income taxes
    (693,085 )     2,178,480       1,053,513  
                         
Net (Loss) Income
  $ (1,664,760 )   $ 3,431,644     $ 1,412,886  
                         
Weighted Average Shares Outstanding
                       
Basic
    7,054,442       7,054,442       7,054,442  
Diluted
    7,054,442       7,054,442       7,061,646  
                         
(Loss) Earnings Per Common Share (Note 2):
                       
Basic
  $ (0.24 )   $ 0.49     $ 0.20  
Diluted
  $ (0.24 )   $ 0.49     $ 0.20  

See Notes to Consolidated Financial Statements.

 
- 58 -


CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

   
Years Ended November 30,
 
   
2010
   
2009
   
2008
 
                   
Net (Loss) Income
  $ (1,664,760 )   $ 3,431,644     $ 1,412,886  
                         
Other Comprehensive Income  (Loss)
                       
Unrealized holding gain (loss) on investments, net of tax* (Note 6, Note 8)
    238,507       791,747       (875,914 )
                         
Comprehensive (Loss) Income
  $ (1,426,253 )   $ 4,223,391     $ 536,972  

*Unrealized holding gain (loss) for the years ended November 2010, 2009, and 2008 is net of a deferred tax (expense) benefit from unrealized gains (losses) of $(14,972), $39,900 and $0, respectively.

See Notes to Consolidated Financial Statements.

 
- 59 -


CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY
FOR THE YEARS ENDED NOVEMBER 30, 2010, 2009 AND 2008

   
COMMON STOCK
   
ADDITIONAL PAID IN
   
RETAINED
   
UNREALIZED
GAIN (LOSS) ON
MARKETABLE
   
TOTAL SHAREHOLDERS’
 
   
SHARES
   
AMOUNT
   
CAPITAL
   
EARNINGS
   
SECURITIES
   
EQUITY
 
                                     
Balance – November 30, 2007
    7,054,442     $ 70,544     $ 2,329,049     $ 28,541,086     $ (190,361 )   $ 30,750,318  
Net Income for the year
    ---       ---